搜索医生

Steven E. Schild, M.D.

  1. Radiation Oncologist
  2. Chair, Radiation Oncology, Arizona
预约门诊

出版物

  1. Chun SG, Hu C, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Kavadi VS, Narayan S, Iyengar P, Robinson C, Rothman J, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2024 Jun 27 Epub 2024 June 27
    View PubMed
  2. Gits HC, Khosravi Flanigan MA, Kapplinger JD, Reisenauer JS, Eiken PW, Breen WG, Vu LH, Welch BT, Harmsen WS, Day CN, Olivier KR, Park SS, Garces YI, Hallemeier CL, Merrell KW, Ashman JB, Schild SE, Grams MP, Lucido JJ, Shen KR, Cassivi SD, Wigle D, Nichols FC, Blackmon S, Tapias LF, Callstrom MR, Owen D. Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy. Chest. 2024 May; 165 (5):1247-1259 Epub 2023 Dec 14
    View PubMed
  3. Rades D, Lomidze D, Jankarashvili N, Lopez Campos F, Navarro-Martin A, Segedin B, Groselj B, Staackmann C, Kristiansen C, Dennis K, Schild SE, Cacicedo J. Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial. Cancers (Basel). 2024 Mar 14; 16 (6)
    View PubMed
  4. Zhang L, Holmes JM, Liu Z, Vora SA, Sio TT, Vargas CE, Yu NY, Keole SR, Schild SE, Bues M, Li S, Liu T, Shen J, Wong WW, Liu W. Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy. Med Phys. 2024 Feb; 51 (2):1484-1498 Epub 2023 Sept 25
    View PubMed
  5. Ding Y, Feng H, Yang Y, Holmes J, Liu Z, Liu D, Wong WW, Yu NY, Sio TT, Schild SE, Li B, Liu W. Deep-learning based fast and accurate 3D CT deformable image registration in lung cancer. Med Phys. 2023 Nov; 50 (11):6864-6880 Epub 2023 June 08
    View PubMed
  6. Hu J, Schild SE, Liu W, Li J, Fatyga M. Improving Dose Volume Histogram (DVH) Based Analysis of Clinical Outcomes Using Modern Statistical Techniques: A Systematic Answer to Multiple Comparisons Concerns. Int J Radiat Oncol Biol Phys. 2023 Oct 1; 117 (2S):S20
    View PubMed
  7. Rades D, Staackmann C, Lomidze D, Jankarashvili N, Lopez F, Navarro A, Segedin B, Groselj B, Kristiansen C, Dennis K, Schild SE, Fernandez JC. Radiotherapy for Metastatic Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial. Int J Radiat Oncol Biol Phys. 2023 Oct 1; 117 (2S):S74
    View PubMed
  8. Duan J, Vargas CE, Yu NY, Laughlin BS, Toesca DS, Keole S, Rwigema JCM, Wong WW, Schild SE, Feng X, Chen Q, Rong Y. Incremental retraining, clinical implementation, and acceptance rate of deep learning auto-segmentation for male pelvis in a multiuser environment. Med Phys. 2023 Jul; 50(7):4079-4091. Epub 2023 Jun 07.
    View PubMed
  9. Rades D, Schild SE. Personalization of Radiation Therapy in the Primary Treatment of Malignant Epidural Spinal Cord Compression (MESCC). Semin Radiat Oncol. 2023 Apr; 33 (2):148-158
    View PubMed
  10. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Patil T, Polanco PM, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hughes M. NCCN Guidelines(R) Insights: Non-Small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. 2023 Apr; 21 (4):340-350
    View PubMed
  11. Ernani V, Appiah AK, Rodriguez D, Kusne Y, Beamer SE, Ravanbakhsh S, Jaroszewski D, Reck Dos Santos P, Sio TT, Yu N, Yang P, Schild S, D'Cunha J. Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database. Cancer. 2023 Mar 15; 129 (6):860-866 Epub 2022 Dec 22
    View PubMed
  12. Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy. Adv Radiat Oncol. 2023 Mar-Apr; 8 (2):101143 Epub 2022 Dec 10
    View PubMed
  13. Rades D, Kristiansen C, Schild SE, Janssen S. Short Communication: Results of a Consensus Conference on Radiotherapy for Brain and Bone Metastases Within the Interreg-Project TreaT. In Vivo. 2023 Mar-Apr; 37 (2):894-897
    View PubMed
  14. Du L, Ernani V, Liu A, Schild SE, Jaroszewski DE, Cassivi SD, Beamer SE, Luo YH, Wampfler JA, Santos PARD, Wigle D, Sun D, Shen KR, Yang P. Prognostic factors in resected pulmonary carcinoid tumors: A retrospective study with 10 years of follow‑up. Oncol Lett. 2023 Feb; 25 (2):80 Epub 2023 Jan 10
    View PubMed
  15. Zwaan I, Soror T, Bruchhage KL, Hakim SG, Schild SE, Rades D. Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck. Anticancer Res. 2023 Feb; 43 (2):795-800
    View PubMed
  16. Rades D, Zwaan I, Janssen S, Yu NY, Schild SE, Idel C, Pries R, Hakim SG, Soror T. Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer. Anticancer Res. 2023 Feb; 43 (2):823-830
    View PubMed
  17. Rades D, Delikanli C, Schild SE, Kristiansen C, Tvilsted S, Janssen S. Comparison of Three Survival Scores in a Series of Patients >/=80 Years of Age Irradiated for Bone Metastases. Anticancer Res. 2023 Feb; 43 (2):801-807
    View PubMed
  18. Rades D, Werner EM, Glatzel E, Bohnet S, Schild SE, Tvilsted SS, Janssen S. Early Identification of Pneumonitis in Patients Irradiated for Lung Cancer-Final Results of the PARALUC Trial. Cancers (Basel). 2023 Jan 4; 15 (2) Epub 2023 Jan 04
    View PubMed
  19. Laughlin BS, Narang GL, Cheney SM, Humphreys MR, Vargas CE, Keole SR, Rwigema JM, Schild SE, Wong WW. Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience. Cancer Rep (Hoboken). 2023 Jan; 6 (1):e1672 Epub 2022 July 05
    View PubMed
  20. Hobbis D, Yu NY, Mund KW, Duan J, Rwigema JM, Wong WW, Schild SE, Keole SR, Feng X, Chen Q, Vargas CE, Rong Y. First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy Patients. Pract Radiat Oncol. 2023 Jul-Aug; 13(4):351-362. Epub 2023 Apr 06.
    View PubMed
  21. Thomson HM, Fortin Ensign SP, Edmonds VS, Sharma A, Butterfield RJ 3rd, Schild SE, Ashman JB, Zimmerman RS, Patel NP, Bryce AH, Vora SA, Sio TT, Porter AB. Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma. Clin Med Insights Oncol. 2023; 17:11795549231161878. Epub 2023 Mar 21.
    View PubMed
  22. Rades D, Kristiansen C, Keil D, Schild SE, Janssen S. Current Radiotherapy Concepts Regarding Brain and Bone Metastases in Centers Participating in the German-Danish Interreg-Project TreaT. In Vivo. 2023 Jan-Feb; 37 (1):329-335
    View PubMed
  23. Laughlin BS, Yu NY, Lo S, Duan J, Welchel Z, Tinnon K, Beckett M, Schild SE, Wong WW, Keole SR, Rwigema JM, Vargas CE, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance. Cancers (Basel). 2022 Dec 21; 15 (1)
    View PubMed
  24. Laughlin BS, Lo S, Vargas CE, DeWees TA, Van der Walt C, Tinnon K, Beckett M, Hobbis D, Schild SE, Wong WW, Keole SR, Rwigema JM, Yu NY, Clouser E, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 1: Consistent Organs at Risk Management with Advanced Image Guidance. Cancers (Basel). 2022 Dec 20; 15 (1)
    View PubMed
  25. Yang Y, Rwigema JM, Vargas C, Yu NY, Keole SR, Wong WW, Schild SE, Bues M, Liu W, Shen J. Technical note: Investigation of dose and LET(d) effect to rectum and bladder by using non-straight laterals in prostate cancer receiving proton therapy. Med Phys. 2022 Dec; 49 (12):7428-7437 Epub 2022 Oct 18
    View PubMed
  26. Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, Liu W, Schild SE, Merrell KW, Sio TT. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 Dec; 23 (8):e526-e535 Epub 2022 Aug 10
    View PubMed
  27. Delikanli C, Janssen S, Keil D, Tvilsted S, Schild SE, Rades D. Distress Scores During a Course of Radiotherapy: A Pilot Study. Anticancer Res. 2022 Nov; 42 (11):5561-5566
    View PubMed
  28. Rades D, Delikanli C, Blanck O, Schild SE, Janssen S. A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy. Anticancer Res. 2022 Nov; 42 (11):5629-5634
    View PubMed
  29. Shan J, Feng H, Morales DH, Patel SH, Wong WW, Fatyga M, Bues M, Schild SE, Foote RL, Liu W. Virtual particle Monte Carlo: A new concept to avoid simulating secondary particles in proton therapy dose calculation. Med Phys. 2022 Oct; 49 (10):6666-6683 Epub 2022 Aug 22
    View PubMed
  30. Rades D, Delikanli C, Schild SE, Kristiansen C, Tvilsted S, Janssen S. The First Survival Score for Patients Aged >/=80 Years Irradiated for Brain Metastases. Biology (Basel). 2022 Sep 30; 11 (10) Epub 2022 Sept 30
    View PubMed
  31. Rades D, Delikanli C, Schild SE, Kristiansen C, Tvilsted S, Janssen S. A New Survival Score for Patients >/=65 Years Assigned to Radiotherapy of Bone Metastases. Cancers (Basel). 2022 Sep 26; 14 (19) Epub 2022 Sept 26
    View PubMed
  32. Rades D, Zwaan I, Cacicedo J, Bruchhage KL, Hakim SG, Olbrich D, Schild SE, Tvilsted S, Janssen S. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02). BMC Cancer. 2022 Sep 17; 22 (1):989 Epub 2022 Sept 17
    View PubMed
  33. Yang Y, Patel SH, Bridhikitti J, Wong WW, Halyard MY, McGee LA, Rwigema JM, Schild SE, Vora SA, Liu T, Bues M, Fatyga M, Foote RL, Liu W. Exploratory study of seed spots analysis to characterize dose and linear-energy-transfer effect in adverse event initialization of pencil-beam-scanning proton therapy. Med Phys. 2022 Sep; 49 (9):6237-6252 Epub 2022 July 21
    View PubMed
  34. Rades D, Kopelke S, Schild SE, Kjaer TW, Tvilsted S, Bartscht T. Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy. Anticancer Res. 2022 Sep; 42 (9):4511-4515
    View PubMed
  35. Rades D, Kopelke S, Schild SE, Tvilsted S, Kjaer TW, Bartscht T. Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction. Anticancer Res. 2022 Sep; 42 (9):4529-4533
    View PubMed
  36. Rades D, Witteler J, Trillenberg P, Olbrich D, Schild SE, Tvilsted S, Kjaer TW. Increasing Seizure Activity During Radiation Treatment for High-grade Gliomas - Final Results of a Prospective Interventional Study. In Vivo. 2022 Sep-Oct; 36 (5):2308-2313
    View PubMed
  37. Rades D, Segedin B, Schild SE, Lomidze D, Veninga T, Cacicedo J. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy. Radiat Oncol. 2022 Aug 17; 17 (1):143
    View PubMed
  38. Rades D, Al-Salool A, Staackmann C, Cremers F, Cacicedo J, Lomidze D, Segedin B, Groselj B, Jankarashvili N, Conde-Moreno AJ, Ciervide R, Kristiansen C, Schild SE. A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression. Cancers (Basel). 2022 Aug 7; 14 (15) Epub 2022 Aug 07
    View PubMed
  39. Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13
    View PubMed
  40. Rades D, Warwas B, Cremers F, Gerull K, Idel C, Bruchhage KL, Hakim SG, Schild SE. Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer. Anticancer Res. 2022 Jul; 42 (7):3551-3556
    View PubMed
  41. Rades D, Warwas B, Gerull K, Pries R, Leichtle A, Bruchhage KL, Hakim SG, Schild SE, Cremers F. Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers. In Vivo. 2022 Jul-Aug; 36 (4):1795-1800
    View PubMed
  42. Rades D, Cacicedo J, Lomidze D, Al-Salool A, Segedin B, Groselj B, Jankarashvili N, Conde-Moreno AJ, Schild SE. A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression. Pract Radiat Oncol. 2022 Jul-Aug; 12 (4):354-362 Epub 2022 Apr 05
    View PubMed
  43. Schild SE, Wang X, Bestvina CM, Williams T, Masters G, Singh AK, Stinchcombe TE, Salama JK, Wolf S, Zemla T, Duma N, Chun SG, Amini A, Kozono D, Watt C. Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. Clin Lung Cancer. 2022 Jul; 23 (5):e317-e320 Epub 2022 Apr 30
    View PubMed
  44. Rades D, Narvaez CA, Dziggel L, Splettstosser L, Janssen S, Olbrich D, Schild SE, Tvilsted S, Kjaer TW. Improvement of Sleep Disorders During a Course of Radiotherapy for Breast Cancer - Final Results of the Prospective Interventional RADIO-SLEEP Trial. Anticancer Res. 2022 Jun; 42 (6):3085-3089
    View PubMed
  45. Rades D, Warwas B, Cremers F, Gerull K, Pries R, Leichtle A, Bruchhage KL, Hakim SG, Schild SE. The First Prognostic Tool to Estimate the Risk of Late Grade >/=3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer. Anticancer Res. 2022 Jun; 42 (6):3035-3039
    View PubMed
  46. Feng H, Patel SH, Wong WW, Younkin JE, Penoncello GP, Morales DH, Stoker JB, Robertson DG, Fatyga M, Bues M, Schild SE, Foote RL, Liu W. GPU-accelerated Monte Carlo-based online adaptive proton therapy: A feasibility study. Med Phys. 2022 Jun; 49 (6):3550-3563 Epub 2022 Apr 27
    View PubMed
  47. Rades D, Cacicedo J, Lomidze D, Al-Salool A, Segedin B, Groselj B, Schild SE. Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression-An Additional Analysis of Patients from Two Prospective Trials. Cancers (Basel). 2022 May 22; 14 (10)
    View PubMed
  48. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico TA, DeCamp M, Dilling TJ, Dowell J, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW Jr, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Pacheco JM, Patel SP, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory K, Hughes M. Non-small cell lung cancer, version 3.2022. Journal of the National Comprehensive Cancer Network. 2022 May; 20 (5):497-530
  49. Werner EM, Glatzel E, Bohnet S, Schild SE, Rades D. Prognostic Factors of Survival After Radiotherapy for Lung Cancer-The Impact of Smoking Pack Years. In Vivo. 2022 May-Jun; 36 (3):1297-1301
    View PubMed
  50. Warwas B, Cremers F, Gerull K, Leichtle A, Bruchhage KL, Hakim SG, Schild SE, Rades D. Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers. Anticancer Res. 2022 May; 42 (5):2657-2663
    View PubMed
  51. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico TA, DeCamp M, Dilling TJ, Dowell J, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Pacheco JM, Patel SP, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory K, Hughes M. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 May; 20 (5):497-530
    View PubMed
  52. Knopf AC, Czerska K, Fracchiolla F, Graeff C, Molinelli S, Rinaldi I, Rucincki A, Sterpin E, Stutzer K, Trnkova P, Zhang Y, Chang JY, Giap H, Liu W, Schild SE, Simone CB 2nd, Lomax AJ, Meijers A. Clinical necessity of multi-image based (4DMIB) optimization for targets affected by respiratory motion and treated with scanned particle therapy - A comprehensive review. Radiother Oncol. 2022 Apr; 169:77-85 Epub 2022 Feb 18
    View PubMed
  53. Rades D, Glatzel E, Bohnet S, Schild SE, Werner EM. Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer. Anticancer Res. 2022 Apr; 42 (4):1973-1977
    View PubMed
  54. Ernani V, Du L, Ross HJ, Yi JE, Wampfler JA, Schild SE, Xie H, Swanson KL, Tazelaar HD, Yang P. Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer. Thorac Cancer. 2022 Apr; 13 (7):925-933 Epub 2022 Feb 23
    View PubMed
  55. Bhangoo RS, Cheng TW, Petersen MM, Thorpe CS, DeWees TA, Anderson JD, Vargas CE, Patel SH, Halyard MY, Schild SE, Wong WW. Radiation recall dermatitis: A review of the literature. Semin Oncol. 2022 Apr; 49 (2):152-159 Epub 2022 Apr 29
    View PubMed
  56. Bhangoo RS, Petersen MM, Bulman GF, Vargas CE, Thorpe CS, Shen J, Wong WW, Rwigema JM, Daniels TB, Keole SR, Schild SE, Rong Y, DeWees TA. Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer. Int J Part Ther. 2022 Spring; 8 (4):37-46 Epub 2021 Sept 08
    View PubMed
  57. Rades D, Kuchler J, Graumuller L, Abusamha A, Schild SE, Gliemroth J. Radiotherapy with or without Decompressive Surgery for Metastatic Spinal Cord Compression: A Retrospective Matched-Pair Study Including Data from Prospectively Evaluated Patients. Cancers (Basel). 2022 Feb 28; 14 (5)
    View PubMed
  58. Kopelke S, Kjaer TW, Tvilsted S, Schild SE, Bartscht T, Rades D. Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas. In Vivo. 2022 Jan-Feb; 36 (1):325-329
    View PubMed
  59. Feng H, Shan J, Anderson JD, Wong WW, Schild SE, Foote RL, Patrick CL, Tinnon KB, Fatyga M, Bues M, Patel SH, Liu W. Per-voxel constraints to minimize hot spots in linear energy transfer-guided robust optimization for base of skull head and neck cancer patients in IMPT. Med Phys. 2022 Jan; 49 (1):632-647 Epub 2021 Dec 10
    View PubMed
  60. Yang Y, Muller OM, Shiraishi S, Harper M, Amundson AC, Wong WW, McGee LA, Rwigema JM, Schild SE, Bues M, Fatyga M, Anderson JD, Patel SH, Foote RL, Liu W. Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study. Front Oncol. 2022; 12:843175 Epub 2022 Mar 03
    View PubMed
  61. Laughlin BS, Silva AC, Vora SA, Keole SR, Wong WW, Schild MH, Schild SE. Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost. Front Oncol. 2022; 12:921465 Epub 2022 Aug 10
    View PubMed
  62. Hansford JR, Huang J, Endersby R, Dodgshun AJ, Li BK, Hwang E, Leary S, Gajjar A, Von Hoff K, Wells O, Wray A, Kotecha RS, Raleigh DR, Stoller S, Mueller S, Schild SE, Bandopadhayay P, Fouladi M, Bouffet E, Huang A, Onar-Thomas A, Gottardo NG. Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data. Neurooncol Adv. 2022 Jan-Dec; 4 (1):vdac056 Epub 2022 Apr 14
    View PubMed
  63. Jin JY, Hu C, Xiao Y, Zhang H, Paulus R, Ellsworth SG, Schild SE, Bogart JA, Dobelbower MC, Kavadi VS, Narayan S, Iyengar P, Robinson C, Greenberger JS, Koprowski C, Machtay M, Curran W, Choy H, Bradley JD, Kong FS. Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617. Cancers (Basel). 2021 Dec 8; 13 (24) Epub 2021 Dec 08
    View PubMed
  64. Yu NY, Sio TT, Ernani V, Savvides P, Schild SE. Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer. J Natl Compr Canc Netw. 2021 Dec; 19 (12):1465-1469
    View PubMed
  65. Rades D, Kopelke S, Tvilsted S, Kjaer TW, Schild SE, Bartscht T. Sleep Disturbances in Lung Cancer Patients Assigned to Definitive or Adjuvant Irradiation. In Vivo. 2021 Nov-Dec; 35 (6):3333-3337
    View PubMed
  66. Anderson J, Hu J, Li J, Daniels TB, Schild SE, Fatyga M. Association Between Radiation Heart Dose and Overall Survival in Lung Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111 (3S):e427-e428
    View PubMed
  67. Rades D, Kopelke S, Soror T, Bartscht T, Tvilsted S, Kjaer TW, Schild SE. Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck Cancer. Anticancer Res. 2021 Oct; 41 (10):5065-5069
    View PubMed
  68. Kopelke S, Bartscht T, Schild SE, Tvilsted S, Kjaer TW, Rades D. Frequency and Risk Factors of Sleep Disturbances in Patients With Prostate Cancer Assigned to Local or Loco-regional Radiotherapy. Anticancer Res. 2021 Oct; 41 (10):5165-5169
    View PubMed
  69. Rades D, Narvaez CA, Dziggel L, Tvilsted S, Kjaer TW, Schild SE, Bartscht T. Emotional Problems Prior to Adjuvant Radiation Therapy for Breast Cancer. In Vivo. 2021 Sep-Oct; 35 (5):2763-2770
    View PubMed
  70. Rades D, Kopelke S, Soror T, Schild SE, Tvilsted S, Kjaer TW, Bartscht T. Sleep Disorders Prior to Adjuvant Radiation Therapy for Gynecological Malignancies. Anticancer Res. 2021 Sep; 41 (9):4407-4410 Epub 2021 Sept 01
    View PubMed
  71. Rades D, Kopelke S, Bartscht T, Schild SE, Tvilsted S, Kjaer TW. Evaluation of Pre-radiotherapy Sleep Disorders in Patients With Rectal or Anal Cancer. Anticancer Res. 2021 Sep; 41 (9):4439-4442
    View PubMed
  72. Niska JR, Hu J, Li J, Herman MG, Thorpe CS, Schild SE, Fatyga M. Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose. J Cancer Ther. 2021 Sep; 12 (9):505-529 Epub 2021 Sept 29
    View PubMed
  73. Younkin JE, Morales DH, Shen J, Ding X, Stoker JB, Yu NY, Sio TT, Daniels TB, Bues M, Fatyga M, Schild SE, Liu W. Technical Note: Multiple energy extraction techniques for synchrotron-based proton delivery systems may exacerbate motion interplay effects in lung cancer treatments. Med Phys. 2021 Sep; 48 (9):4812-4823 Epub 2021 July 29
    View PubMed
  74. Feng H, Shan J, Ashman JB, Rule WG, Bhangoo RS, Yu NY, Chiang J, Fatyga M, Wong WW, Schild SE, Sio TT, Liu W. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma. Med Phys. 2021 Aug; 48 (8):4636-4647 Epub 2021 June 24
    View PubMed
  75. Yang Y, Vargas CE, Bhangoo RS, Wong WW, Schild SE, Daniels TB, Keole SR, Rwigema JM, Glass JL, Shen J, DeWees TA, Liu T, Bues M, Fatyga M, Liu W. Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT). Int J Radiat Oncol Biol Phys. 2021 Jul 15; 110 (4):1189-1199 Epub 2021 Feb 20
    View PubMed
  76. Anderson JD, Hu J, Li J, Schild SE, Fatyga M. Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC). J Cancer Ther. 2021 Jul; 12 (7):409-423
    View PubMed
  77. Rades D, Narvaez CA, Schild SE, Tvilsted S, Kjaer TW. Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer. In Vivo. 2021 Jul-Aug; 35 (4):2253-2260
    View PubMed
  78. Staackmann C, Schild SE, Rades D. Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region. In Vivo. 2021 Jul-Aug; 35 (4):2283-2288
    View PubMed
  79. Bulman GF, Bhangoo RS, DeWees TA, Petersen MM, Thorpe CS, Wong WW, Rwigema JCM, Daniels TB, Keole SR, Schild SE, Vargas CE. Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy. Radiat Oncol J. 2021 Jun; 39 (2):122-128 Epub 2021 June 24
    View PubMed
  80. Rades D, Staackmann C, Ribbat-Idel J, Perner S, Idel C, Bruchhage KL, Hakim SG, Schild SE. A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck. Anticancer Res. 2021 Jun; 41 (6):3055-3058
    View PubMed
  81. Staackmann C, Ribbat-Idel J, Perner S, Idel C, Bruchhage KL, Hakim SG, Schild SE, Rades D. Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival. Anticancer Res. 2021 Jun; 41 (6):3205-3210
    View PubMed
  82. Rades D, Staackmann C, Schild SE. Karnofsky Performance Score - An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer. Anticancer Res. 2021 May; 41 (5):2495-2499
    View PubMed
  83. Rades D, Witteler J, Olbrich D, Trillenberg P, Schild SE, Tvilsted S, Kjaer TW. A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG). BMC Cancer. 2021 Apr 9; 21 (1):386 Epub 2021 Apr 09
    View PubMed
  84. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dowell J, Gettinger S, Gubens MA, Hegde A, Hennon M, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW Jr, Lovly CM, Martins RG, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Riely GJ, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Yanagawa J, Yang SC, Gregory KM, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw. 2021 Mar 2; 19 (3):254-266 Epub 2021 Mar 02
    View PubMed
  85. Zeng J, Badiyan SN, Garces YI, Wong T, Zhang X, Simone CB 2nd, Chang JY, Knopf AC, Mori S, Iwata H, Meijers A, Li H, Bues M, Liu W, Schild SE, Rengan R, International Particle Therapy Cooperative Group Thoracic Subcommittee. Consensus Statement on Proton Therapy in Mesothelioma. Pract Radiat Oncol. 2021 Mar-Apr; 11 (2):119-133 Epub 2020 May 24
    View PubMed
  86. Rades D, Narvaez CA, Janssen S, SchrOder U, Bruchhage KL, Hakim SG, Bartscht T, Schild SE. Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer. Anticancer Res. 2021 Feb; 41 (2):877-884
    View PubMed
  87. Chiang JS, Yu NY, Daniels TB, Liu W, Schild SE, Sio TT. Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations. J Thorac Dis. 2021 Feb; 13 (2):1270-1285
    View PubMed
  88. Rades D, Cacicedo J, Conde-Moreno AJ, Segedin B, Lomidze D, Ciervide R, Hollaender NH, Schild SE. Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials. Radiat Oncol. 2021 Jan 7; 16 (1):7 Epub 2021 Jan 07
    View PubMed
  89. Narvaez C, Schild SE, Rades D. Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer. In Vivo. 2021 Jan-Feb; 35 (1):411-415
    View PubMed
  90. Witteler J, Schild SE, Rades D. Palliative Radiotherapy of Primary Glioblastoma. In Vivo. 2021 Jan-Feb; 35 (1):483-487
    View PubMed
  91. Rades D, Witteler J, Schild SE, Trillenberg P, Bonsanto MM, Leppert J. A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme. Anticancer Res. 2021 Jan; 41 (1):379-384
    View PubMed
  92. Narvaez CA, Schild SE, Janssen S, Schroeder U, Bruchhage KL, Hakim SG, Rades D. Accelerated Fractionation With Concomitant Boost vs. Conventional Radio-chemotherapy for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head-and-Neck (SCCHN). Anticancer Res. 2021 Jan; 41 (1):477-484
    View PubMed
  93. Witteler J, Schild SE, Rades D. Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM). Anticancer Res. 2020 Dec; 40 (12):7025-7030 Epub 2020 Dec 07
    View PubMed
  94. Rades D, Witteler J, Leppert J, Schild SE. Re-Irradiation for Recurrent Glioblastoma Multiforme. Anticancer Res. 2020 Dec; 40 (12):7077-7081
    View PubMed
  95. Craft DF, Lentz J, Armstrong M, Foster M, Gagneur J, Harrington D, Schild SE, Fatyga M. Three-Dimensionally Printed On-Skin Radiation Shields Using High-Density Filament. Pract Radiat Oncol. 2020 Nov - Dec; 10 (6):e543-e550 Epub 2020 May 13
    View PubMed
  96. Witteler J, Kjaer TW, Tvilsted S, Schild SE, Rades D. Re-Evaluation of Prognostic Factors for Survival After Radiotherapy of Cerebral Gliomas: A Supplementary Analysis to a Previous Study. Anticancer Res. 2020 Nov; 40 (11):6513-6515
    View PubMed
  97. Rades D, Witteler J, Schild SE. Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival. In Vivo. 2020 Nov-Dec; 34 (6):3627-3630
    View PubMed
  98. Witteler J, Schild SE, Rades D. Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas. In Vivo. 2020 Nov-Dec; 34 (6):3719-3722
    View PubMed
  99. Shan J, Yang Y, Schild SE, Daniels TB, Wong WW, Fatyga M, Bues M, Sio TT, Liu W. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer. Med Phys. 2020 Nov; 47 (11):5428-5440 Epub 2020 Oct 13
    View PubMed
  100. Feng H, Sio TT, Rule WG, Bhangoo RS, Lara P, Patrick CL, Korte S, Fatyga M, Wong WW, Schild SE, Ashman JB, Liu W. Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy. J Appl Clin Med Phys. 2020 Nov; 21 (11):141-152 Epub 2020 Oct 15
    View PubMed
  101. Yu NY, Sio TT, Lyons MK, Vora SA, Turkmani A, Brown PD, Park SS, Leenstra JL, Bendok BR, Schild SE, Ashman JB. Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience. J Clin Neurosci. 2020 Oct; 80:74-78 Epub 2020 Aug 17
    View PubMed
  102. Rades D, Bartscht T, Hunold P, Schmidberger H, Konig L, Debus J, Belka C, Homann N, Spillner P, Petersen C, Kuhnt T, Fietkau R, Ridwelski K, Karcher-Kilian K, Kranich A, Mannikko S, Schild SE, Maderer A, Moehler M. Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2). Strahlenther Onkol. 2020 Sep; 196 (9):795-804 Epub 2020 June 12
    View PubMed
  103. Rades D, Witteler J, Kjaer TW, Tvilsted S, Schild SE. Pre-operative Seizures in Patients With Single Brain Metastasis Treated With Resection Plus Whole-Brain Irradiation and a Boost. In Vivo. 2020 Sep-Oct; 34 (5):2705-2709
    View PubMed
  104. Witteler J, Kjaer TW, Tvilsted S, Schild SE, Rades D. Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy. In Vivo. 2020 Sep-Oct; 34 (5):2727-2731
    View PubMed
  105. Rades D, Haus R, Janssen S, Schild SE. An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer. Transl Lung Cancer Res. 2020 Aug; 9 (4):1067-1073
    View PubMed
  106. Rades D, Nguyen T, Janssen S, Schild SE. Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer. Transl Lung Cancer Res. 2020 Aug; 9 (4):1433-1440
    View PubMed
  107. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. Int J Radiat Oncol Biol Phys. 2020 Jul 15; 107 (4):631-640
    View PubMed
  108. Rades D, Nguyen T, Blanck O, Schild SE. Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly. In Vivo. 2020 Jul-Aug; 34 (4):1909-1913
    View PubMed
  109. Witteler J, Kjaer TW, Tvilsted S, Schild SE, Rades D. Seizures Prior to Radiotherapy of Gliomas: Prevalence, Risk Factors and Survival Prognosis. Anticancer Res. 2020 Jul; 40 (7):3961-3965
    View PubMed
  110. Rades D, Nguyen T, Dziggel L, Blanck O, Schild SE. Predicting the Risk of Subsequent Distant Brain Metastases After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy in Elderly Patients. Anticancer Res. 2020 Jul; 40 (7):4081-4086
    View PubMed
  111. Chow R, Hoskin P, Schild SE, Raman S, Im J, Zhang D, Chan S, Chiu N, Chiu L, Lam H, Chow E, Lock M. Corrigendum to "Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis" [Radiother Oncol 141 (2019) 56-61]. Radiother Oncol. 2020 Jul; 148:115 Epub 2020 Apr 01
    View PubMed
  112. Rades D, Witteler J, Dziggel L, Kjaer TW, Tvilsted S, Schild SE. Seizures Prior to Whole-brain Irradiation for Metastatic Disease: Prevalence, Risk Factors and Association With Survival. Anticancer Res. 2020 Jun; 40 (6):3429-3434
    View PubMed
  113. Rades D, Witteler J, Kjaer TW, Tvilsted S, Schild SE. Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases. Anticancer Res. 2020 Jun; 40 (6):3499-3504
    View PubMed
  114. Yu NY, DeWees TA, Liu C, Daniels TB, Ashman JB, Beamer SE, Jaroszewski DE, Ross HJ, Paripati HR, Rwigema JM, Ding JX, Shan J, Liu W, Schild SE, Sio TT. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience. Adv Radiat Oncol. 2020 May-Jun; 5 (3):450-458 Epub 2019 Aug 21
    View PubMed
  115. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 May; 146:223-229 Epub 2020 Apr 06
    View PubMed
  116. Rades D, Nguyen T, Schild SE. The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer. In Vivo. 2020 May-Jun; 34 (3):1317-1320
    View PubMed
  117. Rades D, Nguyen T, Schild SE. Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer. In Vivo. 2020 May-Jun; 34 (3):1321-1324
    View PubMed
  118. Nguyen T, Janssen S, Schild SE, Rades D. A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases. In Vivo. 2020 May-Jun; 34 (3):1361-1364
    View PubMed
  119. Rades D, Nguyen T, Schild SE. Elderly Patients With Single Brain Metastasis - Overall Survival After Surgery Plus Whole-Brain Irradiation and a Radiation Boost. In Vivo. 2020 May-Jun; 34 (3):1421-1425
    View PubMed
  120. Rades D, Nguyen T, Schild SE. Extra-cerebral Metastasis - An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT). Anticancer Res. 2020 May; 40 (5):2841-2845
    View PubMed
  121. Rades D, Nguyen T, Khoa MT, Janssen S, Schild SE. Evaluation of Five Survival Scores in a Cohort of Elderly Patients With Cerebral Metastasis from Non-small Cell Lung Cancer. Anticancer Res. 2020 May; 40 (5):2847-2851
    View PubMed
  122. Yu NY, DeWees TA, Alam M, Ochoa SA, Mangold AR, Steidley DE, Vargas HE, Golafshar MA, Schild SE, Halyard MY, Patel SH. Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients. Am J Clin Oncol. 2020 May; 43 (5):366-370
    View PubMed
  123. Liu C, Patel SH, Shan J, Schild SE, Vargas CE, Wong WW, Ding X, Bues M, Liu W. Robust Optimization for Intensity Modulated Proton Therapy to Redistribute High Linear Energy Transfer from Nearby Critical Organs to Tumors in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2020 May 1; 107 (1):181-193 Epub 2020 Jan 25
    View PubMed
  124. Rades D, Nguyen T, Janssen S, Schild SE. An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer. Anticancer Res. 2020 Apr; 40 (4):2257-2260
    View PubMed
  125. Rades D, Nguyen T, Khoa MT, Janssen S, Schild SE. Remaining Lifespan of Patients Aged >/=65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary. Anticancer Res. 2020 Apr; 40 (4):2261-2264
    View PubMed
  126. Rades D, Nguyen T, Janssen S, Khoa MT, Schild SE. Individualisation of Radiation Therapy for Older Persons With Secondary Brain Lesions from Carcinoma of the Breast. Anticancer Res. 2020 Apr; 40 (4):2271-2274
    View PubMed
  127. Rades D, Nguyen T, Janssen S, Schild SE. An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer. Cancers (Basel). 2020 Mar 30; 12 (4)
    View PubMed
  128. Rades D, Cacicedo J, Conde-Moreno AJ, Segedin B, But-Hadzic J, Groselj B, Kevlishvili G, Lomidze D, Ciervide-Jurio R, Rubio C, Perez-Romasanta LA, Alvarez-Gracia A, Olbrich D, Doemer C, Schild SE, Hollaender NH. Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial. Int J Radiat Oncol Biol Phys. 2020 Mar 15; 106 (4):780-789 Epub 2019 Dec 05
    View PubMed
  129. Haus R, Janssen S, Schild SE, Rades D. Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer. In Vivo. 2020 Mar-Apr; 34 (2):679-682
    View PubMed
  130. Rades D, Haus R, Janssen S, Schild SE. Interval Between Cancer Diagnosis and Radiotherapy - An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer. In Vivo. 2020 Mar-Apr; 34 (2):767-770
    View PubMed
  131. Nguyen T, Bartscht T, Schild SE, Rades D. A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation. Anticancer Res. 2020 Mar; 40 (3):1661-1664
    View PubMed
  132. Nguyen T, Bartscht T, Schild SE, Rades D. Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer. Anticancer Res. 2020 Mar; 40 (3):1665-1668
    View PubMed
  133. Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, Olson MR, Meng J, Paulus R, Curran WJ Jr, Choy H. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. J Clin Oncol. 2020 Mar 1; 38 (7):706-714 Epub 2019 Dec 16
    View PubMed
  134. Deng W, Ding X, Younkin JE, Shen J, Bues M, Schild SE, Patel SH, Liu W. Hybrid 3D analytical linear energy transfer calculation algorithm based on precalculated data from Monte Carlo simulations. Med Phys. 2020 Feb; 47 (2):745-752 Epub 2019 Dec 10
    View PubMed
  135. Sharma A, Mountjoy LJ, Butterfield RJ, Zhang N, Ross HJ, Schild SE, Sio TT, Daniels TB, Paripati HR, Mrugala MM, Vora SA, Patel NP, Zimmerman RS, Ashman JB, Porter AB. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review. Am J Clin Oncol. 2020 Feb; 43 (2):128-132
    View PubMed
  136. Haus R, Janssen S, Schild SE, Rades D. A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer. Anticancer Res. 2020 Jan; 40 (1):287-291
    View PubMed
  137. Janssen S, Haus R, Schild SE, Rades D. A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases. Anticancer Res. 2020 Jan; 40 (1):367-371
    View PubMed
  138. Liu X, Fatyga M, Schild SE, Li J. Detecting spatial susceptibility to cardiac toxicity of radiation therapy for lung cancer. IISE Trans Healthc Syst Eng. 2020; 10 (4):243-250 Epub 2020 July 22
    View PubMed
  139. Schenk EL, Mandrekar SJ, Dy GK, Aubry MC, Tan AD, Dakhil SR, Sachs BA, Nieva JJ, Bertino E, Lee Hann C, Schild SE, Wadsworth TW, Adjei AA, Molina JR. A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. J Thorac Oncol. 2020 Jan; 15 (1):110-119 Epub 2019 Oct 09
    View PubMed
  140. Palmer JD, Trifiletti DM, Gondi V, Chan M, Minniti G, Rusthoven CG, Schild SE, Mishra MV, Bovi J, Williams N, Lustberg M, Brown PD, Rao G, Roberge D. Multidisciplinary patient-centered management of brain metastases and future directions. Neurooncol Adv. 2020 Jan-Dec; 2 (1):vdaa034 Epub 2020 Mar 16
    View PubMed
  141. Chow R, Hoskin P, Schild SE, Raman S, Im J, Zhang D, Chan S, Chiu N, Chiu L, Lam H, Chow E, Lock M. Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis. Radiother Oncol. 2019 Dec; 141:56-61 Epub 2019 Aug 21
    View PubMed
  142. Ettinger DS, Wood DE, Aggarwal C, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower M, Gettinger S, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW Jr, Martins RG, Otterson GA, Patel SP, Reckamp KL, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer KW, Yang SC, Gregory K, Hughes M, OCN. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. J Natl Compr Canc Netw. 2019 Dec; 17 (12):1464-1472
    View PubMed
  143. Valencia-Sanchez C, Gorelkin VC, Mrugala MM, Sharma A, Vora SA, Ashman JB, Daniels TB, Halyard MY, Rule WG, Zhang N, Butterfield RJ, Schild SE, Porter AB. Clinical evaluation of fitness to drive in patients with brain metastases. Neurooncol Pract. 2019 Dec; 6 (6):484-489 Epub 2019 July 03
    View PubMed
  144. Rades D, Haus R, Schild SE, Janssen S. Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases. BMC Cancer. 2019 Nov 28; 19 (1):1156
    View PubMed
  145. Rades D, Segedin B, Conde-Moreno AJ, Ferrer-Albiach C, Metz M, Polat B, Badakhshi H, Schreiber A, Nitsche M, Cacicedo J, Schild SE. Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy x 5 to 3 Gy x 10 for Metastatic Epidural Spinal Cord Compression. Int J Radiat Oncol Biol Phys. 2019 Nov 15; 105 (4):760-764 Epub 2019 Aug 12
    View PubMed
  146. Liu C, Yu NY, Shan J, Bhangoo RS, Daniels TB, Chiang JS, Ding X, Lara P, Patrick CL, Archuleta JP, DeWees T, Hu Y, Schild SE, Bues M, Sio TT, Liu W. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC). Med Phys. 2019 Nov; 46 (11):4755-4762 Epub 2019 Sept 21
    View PubMed
  147. Treder M, Janssen S, Schild SE, Rades D. Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients. Anticancer Res. 2019 Nov; 39 (11):6217-6222
    View PubMed
  148. Sio TT, Mohindra P, Yu NY, Ashman JB, Daniels TB, Merrell KW, Schild SE. The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues. J Clin Oncol 2019 Oct 10; 37 (29):2697-2699 Epub 2019 Aug 29
    View PubMed
  149. Rades D, Narvaez CA, Splettstosser L, Domer C, Setter C, Idel C, Ribbat-Idel J, Perner S, Bartscht T, Olbrich D, Schild SE, Carl J. A randomized trial (RAREST-01) comparing Mepitel(R) Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). Radiother Oncol. 2019 Oct; 139:79-82 Epub 2019 Aug 17
    View PubMed
  150. Chun SG, Schild SE, Bogart JA. Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer? JAMA Oncol. 2019 Aug 1; 5 (8):1229
    View PubMed
  151. Rades D, Hansen HC, Dziggel L, Janssen S, Schild SE. Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases. Anticancer Res. 2019 Aug; 39 (8):4273-4277
    View PubMed
  152. Rades D, Motisi L, Veninga T, Conde-Moreno A, Cacicedo J, Schild SE. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer. Clin Lung Cancer. 2019 Jul; 20 (4):322-329 Epub 2019 Apr 26
    View PubMed
  153. Schild SE, Zhao L, Wampfler JA, Daniels TB, Sio T, Ross HJ, Paripati H, Marks RS, Yi J, Liu H, He Y, Yang P. Small-cell Lung Cancer in Very Elderly (>/= 80 Years) Patients. Clin Lung Cancer. 2019 Jul; 20 (4):313-321 Epub 2019 May 11
    View PubMed
  154. Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol. 2019 Jun 17; 14 (1):108 Epub 2019 June 17
    View PubMed
  155. Rades D, Hansen HC, Schild SE, Janssen S. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer. Lung. 2019 Jun; 197 (3):321-326 Epub 2019 Mar 29
    View PubMed
  156. Janssen S, Hansen HC, Dziggel L, Schild SE, Rades D. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort. Radiol Oncol. 2019 May 8; 53 (2):219-224 Epub 2019 May 08
    View PubMed
  157. Rades D, Hansen HC, Janssen S, Schild SE. Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer. Anticancer Res. 2019 May; 39 (5):2569-2574
    View PubMed
  158. Hansen HC, Janssen S, Schild SE, Rades D. Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool. Anticancer Res. 2019 Apr; 39 (4):2091-2095
    View PubMed
  159. Hansen HC, Janssen S, Thieme C, Perlov A, Schild SE, Rades D. Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses. Anticancer Res. 2019 Mar; 39 (3):1343-1346
    View PubMed
  160. Rades D, Sehmisch L, Hansen HC, Dziggel L, Janssen S, Schild SE. Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM. Anticancer Res. 2019 Mar; 39 (3):1501-1505
    View PubMed
  161. Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 Mar 1; 103 (3):686-696 Epub 2018 Nov 02
    View PubMed
  162. Rades D, Hansen HC, Janssen S, Schild SE. Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases. Cancers (Basel). 2019 Feb 16; 11 (2)
    View PubMed
  163. Schild SE, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Pang HH, Wang X. Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 Feb; 14 (2):298-303 Epub 2018 Oct 04
    View PubMed
  164. Stinchcombe TE, Fan W, Schild SE, Vokes EE, Bogart J, Le QT, Thomas CR, Edelman MJ, Horn L, Komaki R, Cohen HJ, Kishor Ganti A, Pang H, Wang X. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients. Cancer. 2019 Feb 1; 125 (3):382-390 Epub 2018 Oct 21
    View PubMed
  165. Shan J, Sio TT, Liu C, Schild SE, Bues M, Liu W. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy. Med Phys. 2019 Jan; 46 (1):382-393 Epub 2018 Nov 30
    View PubMed
  166. Younkin JE, Morales DH, Shen J, Shan J, Bues M, Lentz JM, Schild SE, Stoker JB, Ding X, Liu W. Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems. Technol Cancer Res Treat. 2019 Jan-Dec; 18:1533033819887182
    View PubMed
  167. Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Schild SE. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression. Radiat Oncol. 2018 Dec 29; 13 (1):257
    View PubMed
  168. Hansen HC, Janssen S, Thieme C, Perlov A, Schild SE, Rades D. Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter? Anticancer Res. 2018 Dec; 38 (12):6835-6840
    View PubMed
  169. Rades D, Sondermann L, Motisi L, Janssen S, Cacicedo J, Schild SE. Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder. Anticancer Res. 2018 Dec; 38 (12):6841-6846
    View PubMed
  170. Rades D, Vogelsang RP, Treder M, Janssen S, Schild SE, Hollander NH, Gogenur I. A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers. Anticancer Res. 2018 Dec; 38 (12):6877-6880
    View PubMed
  171. Rades D, Panzner A, Janssen S, Dunst J, Veninga T, Hollander NH, Schild SE. Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer. Anticancer Res. 2018 Dec; 38 (12):6897-6903
    View PubMed
  172. Niska JR, Thorpe CS, Allen SM, Daniels TB, Rule WG, Schild SE, Vargas CE, Mookadam F. Radiation and the heart: systematic review of dosimetry and cardiac endpoints. Expert Rev Cardiovasc Ther. 2018 Dec; 16 (12):931-950 Epub 2018 Nov 01
    View PubMed
  173. Treder M, Vogelsang RP, Janssen S, Schild SE, Hollander NH, Rades D. Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer. In Vivo. 2018 Nov-Dec; 32 (6):1481-1484
    View PubMed
  174. Liu C, Sio TT, Deng W, Shan J, Daniels TB, Rule WG, Lara PR, Korte SM, Shen J, Ding X, Schild SE, Bues M, Liu W. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study. J Appl Clin Med Phys. 2018 Nov; 19 (6):140-148 Epub 2018 Oct 17
    View PubMed
  175. Stinchcombe TE, Fan W, Schild SE, Vokes EE, Bogart J, Le QX, Thomas CR Jr, Edelman M, Horn L, Komaki R, Cohen HJ, Ganti AK, Pang H, Wang X. A pooled analysis of individual patient data (IPD) of concurrent chemoradiotherapy for limited-stage small cell lung cancer (LS-SCLC) in elderly compared to younger patients (pts) who participated in US National Cancer Institute cooperative group studies. Ann Oncol. 2018 Oct; 29 Suppl 8:viii597-viii598
    View PubMed
  176. Treder M, Janssen S, Hollander NH, Schild SE, Rades D. Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer. Anticancer Res. 2018 Sep; 38 (9):5371-5377
    View PubMed
  177. Schild SE, Pang HH, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Wang X. Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC. J Thorac Oncol. 2018 Aug; 13 (8):1171-1182 Epub 2018 Apr 22
    View PubMed
  178. Rades D, Dziggel L, Schild SE. A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy. In Vivo. 2018 Jul-Aug; 32 (4):825-828
    View PubMed
  179. Staackmann C, Janssen S, Schild SE, Rades D. A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer. Anticancer Res. 2018 Jul; 38 (7):4199-4202
    View PubMed
  180. Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018 Jul; 16 (7):807-821
    View PubMed
  181. Niska JR, Schild SE, Rule WG, Daniels TB, Jett JR. Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease. Clin Lung Cancer. 2018 Jul; 19 (4):e417-e420 Epub 2018 Feb 17
    View PubMed
  182. Liu C, Schild SE, Chang JY, Liao Z, Korte S, Shen J, Ding X, Hu Y, Kang Y, Keole SR, Sio TT, Wong WW, Sahoo N, Bues M, Liu W. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 Jun 1; 101 (2):479-489 Epub 2018 Feb 14
    View PubMed
  183. Rades D, Bartscht T, Idel C, Schild SE, Hakim SG. Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with >/=42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer. Anticancer Res. 2018 Jun; 38 (6):3653-3656
    View PubMed
  184. Janssen S, Hansen HC, Schild SE, Rades D. An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer. Anticancer Res. 2018 Jun; 38 (6):3753-3756
    View PubMed
  185. Urbanic JJ, Wang X, Bogart JA, Stinchcombe TE, Hodgson L, Schild SE, Bazhenova L, Hahn O, Salgia R, Vokes EE. Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance). Int J Radiat Oncol Biol Phys. 2018 May 1; 101 (1):177-185 Epub 2018 Jan 31
    View PubMed
  186. Rades D, Dziggel L, Manig L, Janssen S, Khoa MT, Duong VN, Khiem VH, Schild SE. Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder. In Vivo. 2018 May-Jun; 32 (3):633-636
    View PubMed
  187. Rades D, Dziggel L, Blanck O, Gebauer N, Bartscht T, Schild SE. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma. Anticancer Res. 2018 May; 38 (5):2973-2976
    View PubMed
  188. Rades D, Dziggel L, Blanck O, Gebauer N, Bartscht T, Schild SE. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy. Anticancer Res. 2018 May; 38 (5):3111-3114
    View PubMed
  189. Dziggel L, Gebauer N, Bartscht T, Schild SE, Rades D. Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer. Anticancer Res. 2018 Apr; 38 (4):2391-2394
    View PubMed
  190. Rades D, Dziggel L, Janssen S, Khoa MT, Duong VN, Khiem VH, Gebauer N, Bartscht T, Schild SE. Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases. Anticancer Res. 2018 Apr; 38 (4):2415-2418
    View PubMed
  191. Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):40-48 Epub 2017 Dec 26
    View PubMed
  192. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL. Data collection of patient outcomes: one institution's experience. J Radiat Res. 2018 Mar 1; 59 (suppl_1):i19-i24
    View PubMed
  193. Rades D, Seidl D, Janssen S, Hakim SG, Wollenberg B, Bartscht T, Schild SE. A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers. Anticancer Res. 2018 Mar; 38 (3):1611-1613
    View PubMed
  194. Rades D, Blanck O, Khoa MT, VAN Thai P, Hung NQ, Dziggel L, Schild SE. Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases. In Vivo. 2018 Mar-Apr; 32 (2):381-384
    View PubMed
  195. Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Rudat V, Schild SE. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups. Radiat Oncol. 2018 Feb 8; 13 (1):21 Epub 2018 Feb 08
    View PubMed
  196. Rades D, Conde-Moreno AJ, Cacicedo J, Segedin B, Stanic K, Metz M, Rudat V, Schild SE. Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial. Anticancer Res. 2018 Feb; 38 (2):1009-1015
    View PubMed
  197. Liu X, Li J, Schild SE, Li J, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance? OMICS J Radiol. 2018; 7 (5) Epub 2018 Dec 03
    View PubMed
  198. Shan J, An Y, Bues M, Schild SE, Liu W. Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint. Med Phys. 2018 Jan; 45 (1):460-469 Epub 2017 Dec 05
    View PubMed
  199. Dziggel L, Bajrovic A, Schild SE, Rades D. Stereotactic Radiosurgery Alone for One to Two Brain Metastases from Cancer of Unknown Primary. Anticancer Res. 2018 Jan; 38 (1):565-567
    View PubMed
  200. An Y, Shan J, Patel SH, Wong W, Schild SE, Ding X, Bues M, Liu W. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk. Med Phys. 2017 Dec; 44 (12):6138-6147 Epub 2017 Oct 26
    View PubMed
  201. Waddle MR, Sio TT, Van Houten HK, Foote RL, Keole SR, Schild SE, Laack N, Daniels TB, Crown W, Shah ND, Miller RC. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients. Int J Radiat Oncol Biol Phys. 2017 Dec 1; 99 (5):1078-1082 Epub 2017 Aug 02
    View PubMed
  202. Wong WW, Anderson EM, Mohammadi H, Daniels TB, Schild SE, Keole SR, Choo CR, Tzou KS, Bryce AH, Ho TH, Quevedo FJ, Vora SA. Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 Dec; 15(6):e969-e975. Epub 2017 Apr 26.
    View PubMed
  203. Schild SE, Sio TT, Daniels TB, Chun SG, Rades D. Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer. J Oncol Pract. 2017 Nov; 13 (11):732-738
    View PubMed
  204. Zhang P, Fan N, Shan J, Schild SE, Bues M, Liu W. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy. J Appl Clin Med Phys. 2017 Sep; 18 (5):29-35 Epub 2017 July 06
    View PubMed
  205. Stinchcombe TE, Zhang Y, Vokes EE, Schiller JH, Bradley JD, Kelly K, Curran WJ Jr, Schild SE, Movsas B, Clamon G, Govindan R, Blumenschein GR, Socinski MA, Ready NE, Akerley WL, Cohen HJ, Pang HH, Wang X. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. J Clin Oncol. 2017 Sep 1; 35 (25):2885-2892 Epub 2017 May 11
    View PubMed
  206. Liu W, Patel SH, Harrington DP, Hu Y, Ding X, Shen J, Halyard MY, Schild SE, Wong WW, Ezzell GE, Bues M. Exploratory study of the association of volumetric modulated arc therapy (VMAT) plan robustness with local failure in head and neck cancer. J Appl Clin Med Phys. 2017 Jul; 18 (4):76-83 Epub 2017 May 14
    View PubMed
  207. Phuong PC, Nam LV, Schild SE, Rades D, Khoa MT. A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy. In Vivo. 2017 Jul-Aug; 31 (4):689-693
    View PubMed
  208. Rades D, Manig L, Janssen S, Schild SE. Factors Impacting the Overall Survival of Patients Irradiated for Invasive Carcinoma of the Urinary Bladder. In Vivo. 2017 Jul-Aug; 31 (4):741-744
    View PubMed
  209. Manig L, Janssen S, Schild SE, Rades D. A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer. In Vivo. 2017 Jul-Aug; 31 (4):745-748
    View PubMed
  210. Phuong PC, Luan ND, Trang VTH, Schild SE, Rades D, Khoa MT. Radiosurgery with a Rotating Gamma System: A Very Effective Treatment for Symptomatic Cerebral Cavernomas. Anticancer Res. 2017 Jul; 37 (7):3729-3733
    View PubMed
  211. Robinson JL, Tzou KS, Parker AS, Heckman MG, Wu KJ, Hilton TW, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Buskirk SJ. GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer. Br J Radiol. 2017 Jul; 90 (1075):20170174 Epub 2017 June 16
    View PubMed
  212. Rades D, Janssen S, Conde-Moreno AJ, Cacicedo J, Metz M, Veninga T, Segedin B, Rudat V, Schild SE. Role of the overall treatment time of radiotherapy with 10 x 3 Gy for outcomes in patients with metastatic spinal cord compression. J Med Imaging Radiat Oncol. 2017 Jun; 61 (3):388-393 Epub 2016 Nov 02
    View PubMed
  213. Janssen S, Manig L, Schild SE, Rades D. Radiotherapy of Primary or Recurrent Bladder Cancer in the Very Elderly. Anticancer Res. 2017 Jun; 37 (6):3287-3290
    View PubMed
  214. Manig L, Janssen S, Schild SE, Rades D. A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder. In Vivo. 2017 May-Jun; 31 (3):435-438
    View PubMed
  215. Janssen S, VAN Oorschot B, Kasmann L, Schild SE, Rades D. Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer Res. 2017 May; 37 (5):2537-2540
    View PubMed
  216. Manig L, Kasmann L, Janssen S, Schild SE, Rades D. Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer. Anticancer Res. 2017 May; 37 (5):2693-2696
    View PubMed
  217. Rades D, Janssen S, Bajrovic A, Khoa MT, Veninga T, Schild SE. A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases. Radiat Oncol. 2017 Apr 24; 12 (1):69
    View PubMed
  218. Kasmann L, Bolm L, Schild SE, Janssen S, Rades D. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer. Lung. 2017 Apr; 195 (2):217-224 Epub 2017 Feb 02
    View PubMed
  219. Schild SE, Hillman SL, Tan AD, Ross HJ, McGinnis WL, Garces YA, Graham DL, Adjei AA, Jett JR, Mayo Clinic, North Central Cancer Treatment Group. Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance). J Thorac Oncol. 2017 Apr; 12 (4):697-703 Epub 2017 Jan 12
    View PubMed
  220. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ, Dobelbower M, Doebele RC, Govindan R, Gubens MA, Hennon M, Horn L, Komaki R, Lackner RP, Lanuti M, Leal TA, Leisch LJ, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Apr; 15: (4)504-535.
    View PubMed
  221. Schild MH, Schild SE, Wong WW, Vora SA, Keole SR, Vargas CE, Daniels TB, Ezzell GA, Nguyen BD, Roarke MC. A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT. Int J Radiat Oncol Biol Phys. 2017 Apr 1; 97 (5):1021-1025 Epub 2017 Feb 01
    View PubMed
  222. Rades D, Janssen S, Bajrovic A, Veninga T, Fischer D, Schild SE. A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers. Int J Gynecol Cancer. 2017 Mar; 27 (3):597-602
    View PubMed
  223. Rades D, Manig L, Janssen S, Schild SE. A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer. Anticancer Res. 2017 Mar; 37: (3)1481-1484.
    View PubMed
  224. Rades D, Manig L, Janssen S, Schild SE. Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer. Anticancer Res. 2017 Mar; 37 (3):1485-1488
    View PubMed
  225. Rades D, Seidl D, Janssen S, Strojan P, Karner K, Bajrovic A, Hakim SG, Wollenberg B, Schild SE. Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers. Eur Arch Otorhinolaryngol. 2017 Feb; 274 (2):1021-1027 Epub 2016 Sept 29
    View PubMed
  226. Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy. J Cancer Ther. 2017 Feb; 8 (2):73-85 Epub 2017 Feb 06
    View PubMed
  227. Rades D, Janssen S, Dziggel L, Blanck O, Bajrovic A, Veninga T, Schild SE. A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases. BMC Cancer. 2017 Jan 6; 17 (1):30 Epub 2017 Jan 06
    View PubMed
  228. Dziggel L, Schild SE, Veninga T, Bajrovic A, Rades D. Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer. In Vivo. 2017 Jan 2; 31 (1):35-38
    View PubMed
  229. Bolm L, Kaesmann L, Bartscht T, Schild SE, Rades D. Outcomes After Radio(chemo)therapy for Non-Metastatic Bile Duct Cancer. In Vivo. 2017 Jan 2; 31 (1):117-120
    View PubMed
  230. An Y, Liang J, Schild SE, Bues M, Liu W. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy. Med Phys. 2017 Jan; 44 (1):28-36 Epub 2017 Jan 03
    View PubMed
  231. Rades D, Bolm L, Schild SE, Bartscht T. Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. Anticancer Res. 2017 Jan; 37: (1)203-206.
    View PubMed
  232. Sehmisch L, Schild SE, Rades D. Development of a Survival Score for Patients with Cerebral Metastases from Melanoma. Anticancer Res. 2017 Jan; 37: (1)249-252.
    View PubMed
  233. Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. J Clin Oncol. 2017 Jan; 35 (1):56-62 Epub 2016 Oct 31
    View PubMed
  234. Bloom BC, Augustyn A, Sepesi B, Patel S, Shah SJ, Komaki RU, Schild SE, Chun SG. Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature. Front Oncol. 2017; 7:228 Epub 2017 Sept 29
    View PubMed
  235. Rades D, Bartscht T, Schild SE. Predictors of survival in patients with brain metastases from gastric cancer. Neoplasma. 2017; 64: (1)136-139.
    View PubMed
  236. Rades D, Veninga T, Conde-Moreno AJ, Cacicedo J, Metz M, Segedin B, Norkus D, Rudat V, Schild SE. Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression Practical Radiation Oncology. 2017; 7: (2)137-44.
  237. Rades D, Schild SE. Lung cancer: Best supportive care - a reasonable option for patients with brain metastases? Nat Rev Clin Oncol 2016 Dec; 13 (12):722-724 Epub 2016 Nov 08
    View PubMed
  238. Seidl D, Schild SE, Wollenberg B, Hakim SG, Rades D. Prognostic Factors in Patients Irradiated for Recurrent Head-and-Neck Cancer. Anticancer Res. 2016 Dec; 36: (12)6547-6550.
    View PubMed
  239. Rades D, Kasmann L, Schild SE, Janssen S. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer. Clin Lung Cancer. 2016 Nov; 17 (6):558-562 Epub 2016 June 02
    View PubMed
  240. Liu W, Patel SH, Shen JJ, Hu Y, Harrington DP, Ding X, Halyard MY, Schild SE, Wong WW, Ezzell GA, Bues M. Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancer. Pract Radiat Oncol. 2016 Nov-Dec; 6 (6):e269-e275 Epub 2016 Feb 13
    View PubMed
  241. Rades D, Seidl D, Wollenberg B, Schild SE, Hakim SG. Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck. Anticancer Res. 2016 Oct; 36 (10):5463-5468
    View PubMed
  242. Janssen S, Bajrovic A, Schild SE, Rades D. A Scoring Instrument to Predict the Survival Prognoses of Patients with Metastatic Epidural Spinal Cord Compression from Gynecological Malignancies. Anticancer Res. 2016 Oct; 36: (10)5469-5472.
    View PubMed
  243. Rades D, Conde-Moreno AJ, Cacicedo J, Segedin B, Rudat V, Schild SE. Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma. Radiol Oncol. 2016 Sep 1; 50 (3):337-40 Epub 2016 July 19
    View PubMed
  244. Dziggel L, Janssen S, Bajrovic A, Veninga T, Trang NT, Khoa MT, Schild SE, Rades D. Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers. Anticancer Res. 2016 Sep; 36: (9)4777-80.
    View PubMed
  245. Rades D, Dziggel L, Veninga T, Bajrovic A, Schild SE. Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer. Anticancer Res. 2016 Sep; 36: (9)4817-9.
    View PubMed
  246. Rades D, Veninga T, Janssen S, Schild SE. Outcomes After Whole-brain Radiotherapy for Brain Metastases with 5x4 Gy: Importance of Overall Treatment Time. Anticancer Res. 2016 Sep; 36 (9):4941-5
    View PubMed
  247. Rades D, Strojan P, Seidl D, Janssen S, Bajrovic A, Kazic N, Hakim SG, Wollenberg B, Schild SE. Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks. J Craniomaxillofac Surg. 2016 Sep; 44 (9):1436-40 Epub 2016 July 07
    View PubMed
  248. Rades D, Seidl D, Janssen S, Wollenberg B, Hakim SG, Schild SE. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future. J Craniomaxillofac Surg. 2016 Sep; 44 (9):1441-4 Epub 2016 July 09
    View PubMed
  249. Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B, Karner K, Strojan P, Schild SE. Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (lascchn): Is 20 mg/m(2) cisplatin on five days every four weeks an alternative to 100 mg/m(2) cisplatin every three weeks? Oral Oncology. 2016 Aug; 59:67-72.
  250. Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B, Karner K, Strojan P, Schild SE. Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks? Oral Oncol. 2016 Aug; 59:67-72
    View PubMed
  251. Rades D, Schild SE. Reply to D.E. Spratt and N. Szerlip. J Clin Oncol 2016 Aug 1; 34 (22):2677-8 Epub 2016 June 20
    View PubMed
  252. Rades D, Kaesmann L, Janssen S, Schild SE. A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers. Lung. 2016 Aug; 194 (4):625-9 Epub 2016 May 02
    View PubMed
  253. Rule WG, Allred JB, Pockaj BA, Markovic SN, DiCaudo DJ, Erickson LA, Deming RL, Schild SE. Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma. Cancer Med. 2016 Aug; 5 (8):1890-6 Epub 2016 July 01
    View PubMed
  254. Lee RJ, Tzou KS, Heckman MG, Hobbs CJ, Rawal B, Diehl NN, Peterson JL, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Wong W, Schild S, Pisansky TM, Buskirk SJ. Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy. BJU Int. 2016 Aug; 118 (2):236-42 Epub 2015 Aug 22
    View PubMed
  255. Rades D, Seidl D, Janssen S, Bajrovic A, Karner K, Strojan P, Schild SE. Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers. BMC Cancer. 2016 Jul 8; 16:437 Epub 2016 July 08
    View PubMed
  256. Rades D, Conde-Moreno AJ, Segedin B, Veninga T, Cacicedo J, Schild SE. A Prognostic Instrument to Estimate the Survival of Elderly Patients Irradiated for Metastatic Epidural Spinal Cord Compression From Lung Cancer. Clin Lung Cancer. 2016 Jul; 17: (4)279-84.
    View PubMed
  257. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling T, Dobelbower M, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Swanson SJ, Stevenson J, Tauer K, Yang SC, Gregory K, Hughes M. Nccn guidelines (r) insights malignant pleural mesothelioma, version 3.2016 featured updates to the nccn guidelines Journal Of The National Comprehensive Cancer Network. 2016 Jul 1; 14: (7)825-36.
  258. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling T, Dobelbower M, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Swanson SJ, Stevenson J, Tauer K, Yang SC, Gregory K, Hughes M. NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016. J Natl Compr Canc Netw. 2016 Jul; 14 (7):825-36
    View PubMed
  259. Liu X, Li J, Wu T, Schild SE, Schild MH, Wong W, Vora S, Fatyga M. Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade >/= 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol. 2016 Jun; 5 (3) Epub 2016 June 13
    View PubMed
  260. Rades D, Janssen S, Bajrovic A, Strojan P, Schild SE. A Total Radiation Dose of 70 Gy Is Required After Macroscopically Incomplete Resection of Squamous Cell Carcinoma of the Head and Neck. Anticancer Res. 2016 Jun; 36 (6):2989-92
    View PubMed
  261. Rades D, Janssen S, Veninga T, Schild SE. Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10x3 Gy for Brain Metastases. Anticancer Res. 2016 Jun; 36: (6)3071-4.
    View PubMed
  262. Rades D, Conde-Moreno AJ, Cacicedo J, Segedin B, Rudat V, Schild SE. Radiation Therapy Alone Provides Excellent Outcomes for Spinal Cord Compression from Vertebral Lymphoma. Anticancer Res. 2016 Jun; 36: (6)3081-3.
    View PubMed
  263. Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B, Schild SE. Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer? Oral Oncol. 2016 Jun; 57:40-5 Epub 2016 Apr 25
    View PubMed
  264. Seidl D, Janssen S, Strojan P, Hakim SG, Wollenberg B, Schild SE, Rades D. Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer. Anticancer Res. 2016 May; 36 (5):2487-91
    View PubMed
  265. Seidl D, Janssen S, Strojan P, Bajrovic A, Schild SE, Rades D. Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer. Anticancer Res. 2016 May; 36 (5):2523-6
    View PubMed
  266. Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB 2nd, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe BS, International Particle Therapy Co-operative Group (PTCOG) Thoracic Subcommittee. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):505-516 Epub 2016 Jan 23
    View PubMed
  267. Liu W, Schild SE, Chang JY, Liao Z, Chang YH, Wen Z, Shen J, Stoker JB, Ding X, Hu Y, Sahoo N, Herman MG, Vargas C, Keole S, Wong W, Bues M. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):523-533 Epub 2015 Nov 10
    View PubMed
  268. Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Gebauer N, Bartscht T, Schild SE. A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression. BMC Cancer. 2016 Apr 25; 16:292
    View PubMed
  269. Janssen S, Kaesmann L, Schild SE, Rades D. Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer. Anticancer Res. 2016 Apr; 36: (4)1825-8.
    View PubMed
  270. Rades D, Bartscht T, Janssen S, Bajrovic A, Segedin B, Schild SE. Forecasting Survival Probabilities After Radiotherapy of Metastatic Epidural Spinal Cord Compression from Colorectal Cancer in the Elderly. Anticancer Res. 2016 Apr; 36: (4)1829-33.
    View PubMed
  271. Rades D, Janssen S, Kasmann L, Bolm L, Schild SE. Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer. Anticancer Res. 2016 Apr; 36: (4)2035-9.
    View PubMed
  272. Schild SE, Vokes EE. Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer. Ann Oncol. 2016 Apr; 27 (4):590-9 Epub 2015 Dec 27
    View PubMed
  273. Kaesmann L, Janssen S, Schild SE, Rades D. Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer. Lung. 2016 Apr; 194 (2):295-8 Epub 2016 Feb 16
    View PubMed
  274. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower MC, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. J Natl Compr Canc Netw. 2016 Mar; 14 (3):255-64
    View PubMed
  275. Rades D, Dziggel L, Janssen S, Blanck O, Hornung D, Schild SE. A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer. Anticancer Res. 2016 Mar; 36: (3)1073-6.
    View PubMed
  276. Kasmann L, Janssen S, Schild SE, Rades D. Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer. Anticancer Res. 2016 Mar; 36: (3)1089-91.
    View PubMed
  277. Salama JK, Gu L, Wang X, Pang HH, Bogart JA, Crawford J, Schild SE, Vokes EE, Ready NE. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE). J Thorac Oncol. 2016 Mar; 11 (3):361-9 Epub 2015 Dec 24
    View PubMed
  278. Rades D, Segedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, Badakhshi H, Schreiber A, Nitsche M, Hipp P, Schulze W, Adamietz IA, Norkus D, Rudat V, Cacicedo J, Schild SE. Radiotherapy With 4 Gy x 5 Versus 3 Gy x 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01). J Clin Oncol. 2016 Feb 20; 34 (6):597-602 Epub 2016 Jan 04
    View PubMed
  279. Kasmann L, Janssen S, Schild SE, Rades D. Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer. Anticancer Res. 2016 Feb; 36: (2)803-5.
    View PubMed
  280. Heckman MG, Robinson JL, Tzou KS, Parker AS, Wu KJ, Hilton TW, Howat WJ, Miller JL, Kreinest PA, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Carroll JS, Buskirk SJ. An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. PLoS One. 2016; 11 (3):e0151785 Epub 2016 Mar 17
    View PubMed
  281. Rades D, Schild SE, Bajrovic A, Janssen S, Bartscht T. Personalized Radiotherapeutic Approaches for Elderly Patients with Epidural Cord Compression from Gastric Cancer. In Vivo. 2016 Jan-Feb; 30: (1)69-72.
    View PubMed
  282. Rades D, Conde-Moreno AJ, Cacicedo J, Szegedin B, Schild SE. Estimating the Survival of Elderly Patients with Renal Cell Carcinoma Presenting with Malignant Spinal Cord Compression. Anticancer Res. 2016 Jan; 36: (1)409-13.
    View PubMed
  283. Rades D, Conde-Moreno AJ, Gebauer N, Bartscht T, Cacicedo J, Segedin B, Schild SE. Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma. Anticancer Res. 2016 Jan; 36: (1)375-8.
    View PubMed
  284. Rades D, Sehmisch L, Janssen S, Schild SE. Prognostic factors after whole-brain radiotherapy alone for brain metastases from malignant melanoma Anticancer Research. 2016; 36: (12)6637-40.
  285. Rades D, Sehmisch L, Bajrovic A, Janssen S, Schild SE. Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma In Vivo. 2016; 30: (6)917-9.
  286. Dziggel L, Dahlke M, Janssen S, Hornung D, Blanck O, Khoa MT, Schild SE, Rades D. Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer. Anticancer Res. 2015 Dec; 35: (12)6793-7.
    View PubMed
  287. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Timmerman RD, Choy H. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93 (4):757-64 Epub 2015 July 17
    View PubMed
  288. Rades D, Conde-Moreno AJ, Garcia R, Veninga T, Schild SE. A Tool to Estimate Survival of Elderly Patients Presenting with Metastatic Epidural Spinal Cord Compression (MESCC) from Cancer of Unknown Primary. Anticancer Res. 2015 Nov; 35: (11)6219-22.
    View PubMed
  289. Rades D, Conde-Moreno AJ, Cacicedo J, Segedin B, Veninga T, Schild SE. Metastatic Spinal Cord Compression: A Survival Score Particularly Developed for Elderly Prostate Cancer Patients. Anticancer Res. 2015 Nov; 35: (11)6189-92.
    View PubMed
  290. Rades D, Dahlke M, Dziggel L, Janssen S, Bajrovic A, Trang NT, Khoa MT, Schild SE. Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients. Anticancer Res. 2015 Oct; 35 (10):5701-4
    View PubMed
  291. Rades D, Huttenlocher S, Bartscht T, Schild SE. Predicting the survival probability of gastric cancer patients developing metastatic epidural spinal cord compression (MESCC). Gastric Cancer. 2015 Oct; 18 (4):881-4 Epub 2015 Jan 15
    View PubMed
  292. Rades D, Huttenlocher S, Segedin B, Perpar A, Conde AJ, Garcia R, Veninga T, Stalpers LJ, Cacicedo J, Rudat V, Schild SE. Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis. Int J Radiat Oncol Biol Phys. 2015 Oct 1; 93 (2):368-72 Epub 2015 June 03
    View PubMed
  293. Schild SE, Tan AD, Wampfler JA, Ross HJ, Yang P, Sloan JA. A new scoring system for predicting survival in patients with non-small cell lung cancer. Cancer Med. 2015 Sep; 4(9):1334-43. Epub 2015 Jun 23.
    View PubMed
  294. Rades D, Conde AJ, Garcia R, Cacicedo J, Segedin B, Perpar A, Schild SE. A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer. Radiat Oncol. 2015 Aug 19; 10:173
    View PubMed
  295. Rades D, Huttenlocher S, Khoa MT, Thai PV, Hornung D, Schild SE. Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients. Oncol Lett. 2015 Aug; 10 (2):1109-1112 Epub 2015 June 11
    View PubMed
  296. Bolm L, Janssen S, Kasmann L, Wellner U, Bartscht T, Schild SE, Rades D. Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. Anticancer Res. 2015 Jul; 35(7):4105-8.
    View PubMed
  297. Foster NR, Renfro LA, Schild SE, Redman MW, Wang XF, Dahlberg SE, Ding K, Bradbury PA, Ramalingam SS, Gandara DR, Shibata T, Saijo N, Vokes EE, Adjei AA, Mandrekar SJ. Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer. J Thorac Oncol. 2015 Jul; 10 (7):1099-106
    View PubMed
  298. Rades D, Huttenlocher S, Gebauer N, Hornung D, Trang NT, Khoa MT, Schild SE. Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma. Anticancer Res. 2015 Jun; 35(6):3571-4.
    View PubMed
  299. Salama JK, Schild SE. Radiation therapy for oligometastatic non-small cell lung cancer. Cancer Metastasis Rev. 2015 Jun; 34 (2):183-93
    View PubMed
  300. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 6.2015 featured updates to the nccn guidelines. J. Natl. Compr. Cancer Netw. 2015 May; 13(5):515-24.
  301. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW Jr, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M, National comprehensive cancer network. Non-Small Cell Lung Cancer, Version 6.2015. J Natl Compr Canc Netw. 2015 May; 13 (5):515-24
    View PubMed
  302. Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses. Radiat Oncol. 2015 Apr 15; 10:90
    View PubMed
  303. Rades D, Huttenlocher S, Seibold ND, Gebhard MP, Thorns C, Hasselbacher K, Wollenberg B, Schild SE. Nuclear expression of p65 (rela) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2015 Mar 6; 15:102.
    View PubMed
  304. Rule WG, Foster NR, Meyers JP, Ashman JB, Vora SA, Kozelsky TF, Garces YI, Urbanic JJ, Salama JK, Schild SE. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. J Geriatr Oncol. 2015 Mar; 6 (2):119-26 Epub 2014 Dec 04
    View PubMed
  305. Liu W, Liao Z, Schild SE, Liu Z, Li H, Li Y, Park PC, Li X, Stoker J, Shen J, Keole S, Anand A, Fatyga M, Dong L, Sahoo N, Vora S, Wong W, Zhu XR, Bues M, Mohan R. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers. Pract Radiat Oncol. 2015 Mar-Apr; 5 (2):e77-86 Epub 2014 Sept 11
    View PubMed
  306. Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015 Feb; 16 (2):187-99 Epub 2015 Jan 16
    View PubMed
  307. Rades D, Schild SE, Karstens JH, Hakim SG. Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck. Anticancer Res. 2015 Jan; 35(1):385-8.
    View PubMed
  308. Rades D, Huttenlocher S, Rudat V, Hornung D, Blanck O, Phuong PC, Khoa MT, Schild SE, Fischer D. Radiosurgery with 20 Gy provides better local control of 1-3 brain metastases from breast cancer than with lower doses. Anticancer Res. 2015 Jan; 35(1):333-6.
    View PubMed
  309. Rades D, Huttenlocher S, Dziggel L, Khoa MT, Van Thai P, Hornung D, Schild SE. A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer. Lung. 2015; 193(2):299-302.
    View PubMed
  310. Zhao Y, Foster NR, Meyers JP, Thomas SP, Northfelt DW, Rowland KM Jr, Mattar BI, Johnson DB, Molina JR, Mandrekar SJ, Schild SE, Bearden JD 3rd, Aubry MC, Adjei AA. A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321. J Thorac Oncol. 2015 Jan; 10 (1):172-80
    View PubMed
  311. Rades D, Huttenlocher S, Dziggel L, Blanck O, Hornung D, Mai KT, Ngo TT, Van Pham T, Schild S. A New tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases. Asian Pacific Journal of Cancer Prevention. 2015; 16(7):2967-70.
    View PubMed
  312. Ryu S, Maranzano E, Schild SE, Sahgal A, Yamada Y, Hoskin P, Rades D, Vichare A, Hahn C, Holt T. International survey of the treatment of metastatic spinal cord compression. J Radiosurg SBRT. 2015; 3 (3):237-245
    View PubMed
  313. Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE. Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer. BMC Cancer. 2014 Dec 11; 14:931.
    View PubMed
  314. Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE, Fischer D. Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery? Radiat Oncol. 2014 Dec 4; 9:267 Epub 2014 Dec 04
    View PubMed
  315. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Govindan R, Grannis FW Jr, Horn L, Jahan TM, Komaki R, Kris MG, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild S, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw. 2014 Dec; 12(12):1738-61.
    View PubMed
  316. Schild MH, Schild SE, Wong WW, Vora SA, Silva AC, Silva AM, Daniels TB, Keole SR. Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost. OMICS J Radiol. 2014 Dec; 3 (4)
    View PubMed
  317. Rades D, Huttenlocher S, Dahlke M, Hornung D, Blanck O, Van Thai P, Trang NT, Khoa MT, Schild SE. Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer. Anticancer Res. 2014 Dec; 34(12):7309-13.
    View PubMed
  318. Schild SE, Rule WG, Ashman JB, Vora SA, Keole S, Anand A, Liu W, Bues M. Proton beam therapy for locally advanced lung cancer: A review. World J Clin Oncol. 2014 Oct 10; 5 (4):568-75
    View PubMed
  319. Huttenlocher S, Sehmisch L, Schild SE, Blank O, Hornung D, Rades D. Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery. Anticancer Res. 2014 Oct; 34(10):5589-92.
    View PubMed
  320. Rades D, Evers JN, Bajrovic A, Veninga T, Karstens JH, Schild SE. Metastatic spinal cord compression: a validated survival score for elderly patients. Strahlenther Onkol. 2014 Oct; 190(10):919-24. Epub 2014 Mar 22.
    View PubMed
  321. Huttenlocher S, Seibold ND, Gebhard MP, Noack F, Thorns C, Hasselbacher K, Wollenberg B, Schild SE, Rades DMD. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol. 2014 Oct; 190(11):1021-7.
    View PubMed
  322. Sehmisch L, Huttenlocher S, Schild SE, Rades D. Estimating survival of patients receiving radiosurgery alone for cerebral metastasis from melanoma. J Dermatol. 2014 Oct; 41(10):918-21.
    View PubMed
  323. Huttenlocher S, Dziggel L, Hornung D, Blanck O, Schild SE, Rades D. A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone. Radiat. oncol. 2014 Sep 20; 9:215.
    View PubMed
  324. Rades D, Hornung D, Blanck O, Martens K, Khoa MT, Trang NT, Huppe M, Terheyden P, Gliemroth J, Schild SE. Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels. Strahlenther Onkol. 2014 Sep; 190(9):786-91. Epub 2014 Mar 25.
    View PubMed
  325. Rades D, Sehmisch L, Huttenlocher S, Blank O, Hornung D, Terheyden P, Gliemroth J, Schild SE. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes. Anticancer Res. 2014 Sep; 34 (9):5079-82
    View PubMed
  326. Kilic E, Schild SE, Thorns C, Bajrovic A, Rades D. Prognostic role of vascular endothelial growth factor and its receptor-1 in patients with esophageal cancer. Anticancer Res. 2014 Sep; 34(9):5221-6.
    View PubMed
  327. Rades D, Evers JN, Rudat V, Bajrovic A, Karstens JH, Schild SE. A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression. BMC Cancer. 2014 Aug 14; 14:589.
    View PubMed
  328. Rades D, Bajrovic A, Schild SE, Thorns C, Kilic E. Biologic factors associated with tumor oxygenation are prognostic in patients with stage III esophageal cancer: long-term results. Anticancer Res. 2014 Aug; 34(8):4351-5.
    View PubMed
  329. Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RL. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014 Aug; 15 (9):1027-38 Epub 2014 June 26
    View PubMed
  330. Rades D, Huttenlocher S, Schild SE, Bartscht T. Metastatic spinal cord compression from pancreatic cancer. Anticancer Res. 2014 Jul; 34(7):3727-30.
    View PubMed
  331. Rades D, Weber A, Bartscht T, Bajrovic A, Karstens JH, Schild SE. A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression. Strahlenther Onkol. 2014 Jun; 190(7):667-70.
    View PubMed
  332. Evers JN, Schild SE, Segedin B, Nagy V, Khoa MT, Trang NT, Rades D. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients. Anticancer Res. 2014 May; 34(5):2455-8.
    View PubMed
  333. Rades D, Weber A, Karstens JH, Schild SE, Bartscht T. Number of extraspinal organs with metastases: a prognostic factor of survival in patients with metastatic spinal cord compression (mscc) from non-small cell lung cancer (nsclc). Anticancer Res. 2014 May; 34(5):2503-7.
    View PubMed
  334. Rades D, Evers JN, Bajrovic A, Veninga T, Schild SE. Re-irradiation of spinal cord compression due to metastasis in elderly patients. Anticancer Res. 2014 May; 34(5):2555-8.
    View PubMed
  335. Rades D, Weber A, Karstens JH, Schild SE, Bartscht T. Prognostic role of the number of involved extraspinal organs in patients with metastatic spinal cord compression. Clin Neurol Neurosurg. 2014 Mar; 118:12-5. Epub 2013 Dec 27
    View PubMed
  336. Wong WW, Pockaj BA, Vora SA, Halyard MY, Gray RJ, Schild SE. Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. Breast J. 2014 Mar-Apr; 20(2):125-30. Epub 2013 Dec 26.
    View PubMed
  337. Rades D, Seibold ND, Gebhard MP, Noack F, Bruchhage KL, Schild SE. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol. 2014 Jan; 190(1):68-74. Epub 2013 Jul 18
    View PubMed
  338. Weber A, Bartscht T, Karstens JH, Schild SE, Rades D. Breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol. 2014; 190(3):283-6.
    View PubMed
  339. Rades D, Segedin B, Nagy V, Schild SE, Trang NT, Khoa MT. Predicting the presence of extracranial metastases in patients with brain metastases upon first diagnosis of cancer. Strahlenther Onkol. 2014; 190(4):405-7.
    View PubMed
  340. Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014; 16 (2):67-75
    View PubMed
  341. Dziggel L, Segedin B, Podvrsnik NH, Oblak I, Schild SE, Rades D. A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone. Strahlenther Onkol. 2014 Jan; 190(1):54-8. Epub 2013 Jul 18.
    View PubMed
  342. Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, Schild SE, Rades D. Brain metastasis from non-small cell lung cancer (NSCLC): prognostic importance of the number of involved extracranial organs. Strahlenther Onkol. 2014 Jan; 190(1):64-7. Epub 2013 Oct 09.
    View PubMed
  343. Rades D, Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, Schild SE. Brain metastasis. Prognostic value of the number of involved extracranial organs. Strahlenther Onkol. 2013 Dec; 189(12):996-1000. Epub 2013 Oct 10.
    View PubMed
  344. Weber A, Bartscht T, Karstens JH, Schild SE, Rades D. Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved. Anticancer Res. 2013 Oct; 33(10):4505-7.
    View PubMed
  345. Rades D, Seibold ND, Schild SE, Gebhard MP, Noack F. Androgen receptor expression prognostic value in locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol. 2013 Oct; 189(10):849-55.
    View PubMed
  346. Rades D, Seibold ND, Gebhard MP, Noack F, Thorns C, Schild SE. Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol. 2013 Oct; 189(10):856-60. Epub 2013 Jul 17
    View PubMed
  347. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE. The first survival score for patients with brain metastases from small cell lung cancer (SCLC). Clin Neurol Neurosurg. 2013 Oct; 115(10):2029-32. Epub 2013 Jul 18.
    View PubMed
  348. Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, Schild SE, Rades D. The number of involved extracranial organs: a new predictor of survival in breast cancer patients with brain metastasis. Clin Neurol Neurosurg. 2013 Oct; 115(10):2108-10. Epub 2013 Aug 02.
    View PubMed
  349. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE, Trang NT, Khoa MT. A new survival score for patients with brain metastases from non-small cell lung cancer. Strahlenther Onkol. 2013 Sep; 189(9):777-81. Epub 2013 Jun 07.
    View PubMed
  350. Heckman MG, Tzou KS, Parker AS, Pisansky TM, Schild SE, Hilton TW, Patel VN, Pelaez L, Khor LY, Peterson JL, Daugherty LC, Vallow LA, Pollack A, Buskirk SJ. Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer. J Radiat Oncol. 2013 Sep 1; 2 (3):309-314
    View PubMed
  351. Gerdan L, Segedin B, Veninga T, Schild SE, Rades D. Number of involved extracranial organs predicts survival in patients with brain metastasis from small cell lung cancer. Anticancer Res. 2013 Sep; 33(9):3887-9.
    View PubMed
  352. Salama JK, Hodgson L, Pang H, Urbanic JJ, Blackstock AW, Schild SE, Crawford J, Bogart JA, Vokes EE, Cancer and Leukemia Group B. A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. J Thorac Oncol. 2013 Aug; 8(8):1043-9.
    View PubMed
  353. Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer. J Urol. 2013 Aug; 190 (2):521-6 Epub 2013 Feb 13
    View PubMed
  354. Seibold ND, Schild SE, Gebhard MP, Noack F, Rades D. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol. 2013 Aug; 189(8):639-46. Epub 2013 Jun 09.
    View PubMed
  355. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE, Trang NT, Khoa MT. A simple survival score for patients with brain metastases from breast cancer. Strahlenther Onkol. 2013 Aug; 189(8):664-7. Epub 2013 Jun 07.
    View PubMed
  356. Seibold ND, Schild SE, Gebhard MP, Noack F, Rades D. Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R. Strahlenther Onkol. 2013 Jul; 189(7):559-65. Epub 2013 May 24.
    View PubMed
  357. Rades D, Dziggel L, Nagy V, Segedin B, Lohynska R, Veninga T, Khoa MT, Trang NT, Schild SE. A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone. Radiother Oncol. 2013 Jul; 108(1):123-7. Epub 2013 Jul 03.
    View PubMed
  358. Rades D, Veninga T, Bajrovic A, Karstens JH, Schild SE. A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression. Strahlenther Onkol. 2013 Jun; 189(6):462-6. Epub 2013 Apr 20.
    View PubMed
  359. Mauguen A, Pignon JP, Burdett S, Domerg C, Fisher D, Paulus R, Mandrekar SJ, Belani CP, Shepherd FA, Eisen T, Pang H, Collette L, Sause WT, Dahlberg SE, Crawford J, O'Brien M, Schild SE, Parmar M, Tierney JF, Le Pechoux C, Michiels S, Surrogate Lung Project Collaborative Group. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. Lancet Oncol. 2013 Jun; 14(7):619-26. Epub 2013 May 14.
    View PubMed
  360. Jett JR, Schild SE, Kesler KA, Kalemkerian GP. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143 (5 Suppl):e400S-e419S
    View PubMed
  361. Dziggel L, Segedin B, Podvrsnik NH, Oblak I, Schild SE, Rades D. Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2013 May; 189(5):364-6. Epub 2013 Mar 23.
    View PubMed
  362. Wang Z, Nabhan M, Schild SE, Stafford SL, Petersen IA, Foote RL, Murad MH. Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2013 May 1; 86 (1):18-26 Epub 2012 Oct 03
    View PubMed
  363. Rades D, Hueppe M, Schild SE. A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care. Cancer. 2013 Feb 15; 119(4):897-903. Epub 2012 Oct 12.
    View PubMed
  364. Rades D, Dziggel L, Nagy V, Segedin B, Lohynska R, Veninga T, Khoa MT, Trang NT, Schild SE. Erratum: A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone (Radiotherapy and Oncology (2013) 108 (123-127)). Radiother Oncol. 2013; 109(2):335.
  365. Dy GK, Mandrekar SJ, Nelson GD, Meyers JP, Adjei AA, Ross HJ, Ansari RH, Lyss AP, Stella PJ, Schild SE, Molina JR, Adjei AA. A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528. J Thorac Oncol. 2013 Jan; 8 (1):79-88
    View PubMed
  366. Rades D, Douglas S, Schild SE. A validated survival score for breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol. 2013 Jan; 189(1):41-6. Epub 2012 Nov 10.
    View PubMed
  367. Rades D, Douglas S, Huttenlocher S, Veninga T, Bajrovic A, Rudat V, Schild SE. Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer. Strahlenther Onkol. 2012 Dec; 188(12):1114-8.
    View PubMed
  368. Heckman MG, Parker AS, Wu KJ, Hilton TW, Ko SJ, Pisansky TM, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. Prostate. 2012 Dec 1; 72 (16):1757-66 Epub 2012 Apr 18
    View PubMed
  369. Kaushik M, Pulido JS, Schild SE, Stafford S. Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84 (5):1145-50 Epub 2012 May 15
    View PubMed
  370. Douglas S, Schild SE, Rades D. Metastatic spinal cord compression in patients with cancer of unknown primary. Estimating the survival prognosis with a validated score. Strahlenther Onkol. 2012 Nov; 188(11):1048-51. Epub 2012 Sep 29.
    View PubMed
  371. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23 (11):2919-2924 Epub 2012 July 10
    View PubMed
  372. Qi Y, Allen Ziegler KL, Hillman SL, Redman MW, Schild SE, Gandara DR, Adjei AA, Mandrekar SJ. Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer. Cancer. 2012 Nov 1; 118 (21):5358-65 Epub 2012 Mar 20
    View PubMed
  373. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23 (11):2919-2924 Epub 2019 Dec 04
    View PubMed
  374. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012 Oct 22; 7:174
    View PubMed
  375. Rades D, Hakim SG, Bajrovic A, Karstens JH, Veninga T, Rudat V, Schild SE. Impact of zoledronic acid on control of metastatic spinal cord compression. Strahlenther Onkol. 2012 Oct; 188(10):910-6. Epub 2012 Aug 19.
    View PubMed
  376. Douglas S, Schild SE, Rades D. A new score predicting the survival of patients with spinal cord compression from myeloma. BMC Cancer. 2012 Sep 25; 12:425.
    View PubMed
  377. Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE. A survival score for patients with metastatic spinal cord compression from prostate cancer. Strahlenther Onkol. 2012 Sep; 188(9):802-6. Epub 2012 Apr 25.
    View PubMed
  378. Rades D, Schild SE. Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? Strahlenther Onkol. 2012 Aug; 188(8):702-6. Epub 2012 Mar 16.
    View PubMed
  379. Rades D, Panzner A, Dziggel L, Haatanen T, Lohynska R, Schild SE. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer. 2012 Aug 1; 118(15):3852-9. Epub 2011 Dec 13.
    View PubMed
  380. Mauguen A, Le Pechoux, Saunders MI, Schild SE, Turrisi AT, Baumann M, Sause WT, Ball D, Belani CP, Bonner JA, Zajusz A, Dahlberg SE, Nankivell M, Mandrekar SJ, Paulus R, Behrendt K, Koch R, Bishop JF, Dische S, Arriagada R, De Ruysscher, Pignon JP. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol. 2012 Aug 1; 30(22):2788-97. Epub 2012 Jul 02.
    View PubMed
  381. Rades D, Douglas S, Veninga T, Poortmans P, Bajrovic A, Hoskin PJ, Rudat V, Schild SE. Prognostic factors for local control and survival in patients with spinal cord compression from myeloma. Strahlenther Onkol. 2012 Jul; 188(7):628-31. Epub 2012 Mar 14.
    View PubMed
  382. Rades D, Hornung D, Veninga T, Schild SE, Gliemroth J. Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy. Cancer. 2012 Jun 1; 118(11):2980-5. Epub 2011 Oct 25.
    View PubMed
  383. Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE. Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients. Strahlenther Onkol. 2012 Jun; 188(6):472-6. Epub 2012 Feb 25.
    View PubMed
  384. Rades D, Huttenlocher S, Evers JN, Bajrovic A, Karstens JH, Rudat V, Schild SE. Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression? Strahlenther Onkol. 2012 May; 188(5):424-30. Epub 2012 Feb 16.
    View PubMed
  385. Rades D, Kueter JD, Meyners T, Pluemer A, Veninga T, Gliemroth J, Schild SE. Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery. Clin Neurol Neurosurg. 2012 May; 114(4):326-30. Epub 2011 Dec 05.
    View PubMed
  386. Reungwetwattana T, Molina JR, Mandrekar SJ, Allen-Ziegler K, Rowland KM, Reuter NF, Luyun RF, Dy GK, Marks RS, Schild SE, Jett JR, Adjei AA. Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study. J Thorac Oncol. 2012 May; 7 (5):919-22
    View PubMed
  387. Rades D, Douglas S, Veninga T, Stalpers LJ, Bajrovic A, Rudat V, Schild SE. Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol. 2012 Apr; 188(4):340-5. Epub 2012 Feb 23.
    View PubMed
  388. Holt T, Hoskin P, Maranzano E, Sahgal A, Schild SE, Ryu S, Loblaw A. Malignant epidural spinal cord compression: the role of external beam radiotherapy. Curr Opin Support Palliat Care. 2012 Mar; 6(1):103-8.
    View PubMed
  389. Rades D, Veninga T, Hornung D, Wittkugel O, Schild SE, Gliemroth J. Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection. Cancer. 2012 Feb 15; 118(4):1138-44. Epub 2011 Jul 14.
    View PubMed
  390. Rades D, Kueter JD, Gliemroth J, Veninga T, Pluemer A, Schild SE. Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis. Strahlenther Onkol. 2012 Feb; 188(2):143-7. Epub 2012 Jan 12.
    View PubMed
  391. Rades D, Douglas S, Veninga T, Schild SE. A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer. 2012; 12:302. Epub 2012 Jul 20.
    View PubMed
  392. Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D. Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer. 2012; 12:261. Epub 2012 Jun 21.
    View PubMed
  393. Rades D, Schild SE. Challenges of anemia correction during radiotherapy and chemoradiation. Memo - Magazine of European Medical Oncology. 2012; 5(1):35-8.
  394. Paripati HR, Karlin NJ, Schild SE, Vora SA, Dueck AC, Ross HJ. Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer-A retrospective analysis. Journal of Geriatric Oncology. 2012; 3(2):104-10.
  395. Rades D, Setter C, Dahl O, Schild SE, Noack F. The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. Cancer. 2012 Jan 1; 118(1):157-63. Epub 2011 Jun 28.
    View PubMed
  396. Rades D, Ulbricht T, Hakim SG, Schild SE. Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity. Strahlenther Onkol. 2012 Jan; 188(1):42-8. Epub 2011 Dec 24.
    View PubMed
  397. Rades D, Setter C, Dahl O, Schild SE, Noack F. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):442-7. Epub 2010 Oct 14.
    View PubMed
  398. Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Adamietz IA, Kazic N, Rudat V, Schild SE. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys. 2011 Dec 1; 81(5):e861-8. Epub 2011 Jan 27.
    View PubMed
  399. Rades D, Schroeder U, Bajrovic A, Schild SE. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis. Eur J Cancer. 2011 Dec; 47(18):2729-34. Epub 2011 Jul 02.
    View PubMed
  400. Rades D, Evers JN, Veninga T, Stalpers LJ, Lohynska R, Schild SE. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e469-73. Epub 2011 Apr 07.
    View PubMed
  401. Wong WW, Schild SE, Vora SA, Ezzell GA, Nguyen BD, Ram PC, Roarke MC. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81 (4):e423-9 Epub 2011 Apr 07
    View PubMed
  402. Rades D, Panzner A, Rudat V, Karstens JH, Schild SE. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis. Strahlenther Onkol. 2011 Nov; 187(11):729-35. Epub 2011 Oct 28.
    View PubMed
  403. Rades D, Seibold ND, Gebhard MP, Noack F, Schild SE, Thorns C. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol. 2011 Oct; 187(10):626-32. Epub 2011 Sep 19.
    View PubMed
  404. Rades D, Meyners T, Kazic N, Bajrovic A, Rudat V, Schild SE. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis. Strahlenther Onkol. 2011 Sep; 187(9):541-7. Epub 2011 Aug 16.
    View PubMed
  405. Rades D, Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, Adamietz IA, Wildfang I, Rudat V, Schild SE, Dunst J. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1492-7. Epub 2010 Jun 25.
    View PubMed
  406. Rades D, Kronemann S, Meyners T, Bohlen G, Tribius S, Kazic N, Schroeder U, Hakim SG, Schild SE, Dunst J. Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2011 Jul 15; 80(4):1037-44. Epub 2010 Jul 16.
    View PubMed
  407. Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J, Schild SE. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys. 2011 Jul 15; 80(4):1122-7. Epub 2010 Jul 16.
    View PubMed
  408. Rades D, Setter C, Dahl O, Schild SE, Noack F. Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 1; 80(2):499-505. Epub 2010 Jun 18.
    View PubMed
  409. Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ. Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1343-9. Epub 2010 Jul 02.
    View PubMed
  410. Rades D, Douglas S, Huttenlocher S, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Adamietz IA, Schild SE. Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5):1503-6. Epub 2010 Jun 03.
    View PubMed
  411. Foster NR, Qi Y, Shi Q, Krook JE, Kugler JW, Jett JR, Molina JR, Schild SE, Adjei AA, Mandrekar SJ. Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials. Cancer. 2011 Mar 15; 117 (6):1262-71 Epub 2010 Oct 19
    View PubMed
  412. Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE. Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2011 Feb 1; 79(2):524-30. Epub 2010 May 06.
    View PubMed
  413. Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol. 2011 Jan 20; 29(3):272-8. Epub 2010 Dec 06.
    View PubMed
  414. Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol. 2011 Jan 20; 29(3):279-86. Epub 2010 Dec 06.
    View PubMed
  415. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA. Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC): findings from a north central cancer treatment group (NCCTG) meta-analysis. J Thoracic Oncol. Submitted 2011.
  416. Dy GK, Hillman SL, Rowland KM, Molina JR, Steen PD, Wender DB, Nair S, Mandrekar S, Schild SE, Adjei AA, North Central. A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326. Cancer. 2010 Dec 15; 116(24):5686-93.
    View PubMed
  417. Schild SE, Behl D, Markovic SN, Brown PD, Sande JR, Deming RL, Rowland KM Jr, Bearden JD. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? Am J Clin Oncol. 2010 Dec; 33 (6):633-6
    View PubMed
  418. Meyners T, Heisterkamp C, Kueter JD, Veninga T, Stalpers LJA, Schild SE, Rades D. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis. BMC Cancer. 2010 Oct 26; 10.
  419. Rades D, Heisterkamp C, Schild SE. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose? Int J Radiat Oncol Biol Phys. 2010 Oct 1; 78(2):398-403. Epub 2010 May 18.
    View PubMed
  420. Dirk R, Meyners T, Veninga T, Stalpers LJA, Schild SE. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys. 2010 Oct 1; 78(2):404-8.
  421. Jatoi A, Schild SE, Foster N, Henning GT, Dornfeld KJ, Flynn PJ, Fitch TR, Dakhil SR, Rowland KM, Stella PJ, Soori GS, Adjei AA. A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422). Ann Oncol. 2010 Oct; 21 (10):2040-2044 Epub 2010 June 21
    View PubMed
  422. Adjei AA, Salavaggione OE, Mandrekar SJ, Dy GK, Ziegler KL, Endo C, Molina JR, Schild SE, Adjei AA. Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. J Thorac Oncol. 2010 Sep; 5 (9):1346-53
    View PubMed
  423. Rades D, Douglas S, Veninga T, Stalpers LJ, Hoskin PJ, Bajrovic A, Adamietz IA, Basic H, Dunst J, Schild SE. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer. 2010 Aug 1; 116(15):3670-3.
    View PubMed
  424. Rades D, Nadrowitz R, Buchmann I, Hunold P, Noack F, Schild SE, Meller B. Radio labeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC). Strahlenther Onkol. 2010 Aug; 186(8):457-61.
  425. Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, Schild SE. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol. 2010 Aug 1; 28(22):3597-604. Epub 2010 Jul 06.
    View PubMed
  426. Rades D, Kronemann S, Meyners T, Schild SE, Hakim SG. Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis. Oral Oncol. 2010 Jul; 46(7):549-52.
    View PubMed
  427. Rades D, Setter C, Dunst J, Dahl O, Schild SE, Noack F. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). Strahlenther Onkol. 2010 Jun; 186(6):307-14. Epub 2010 Apr 26.
    View PubMed
  428. Rades D, Heisterkamp C, Huttenlocher S, Bohlen G, Dunst J, Haatanen T, Schild SE. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Int J Radiat Oncol Biol Phys. 2010 Jun 1; 77(2):537-41. Epub 2009 Sep 03.
    View PubMed
  429. Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, Adamietz IA, Rudat V, Schild SE, Dunst J, Rades D. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors. Strahlenther Onkol. 2010 Apr; 186(4):218-23. Epub 2010 Mar 26.
    View PubMed
  430. Rades D, Schild SE, Abrahm JL. Treatment of painful bone metastases. Nat Rev Clin Oncol. 2010 Apr; 7(4):220-9. Epub 2010 Mar 16.
    View PubMed
  431. Bohlen G, Meyners T, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Rades D. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC). Clin Neurol Neurosurg. 2010 Apr; 112(3):183-7. Epub 2009 Dec 03.
    View PubMed
  432. Bernard JR Jr, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, Schild SE, Pisansky TM. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76 (3):735-40 Epub 2009 May 21
    View PubMed
  433. Heisterkamp C, Haatanen T, Schild SE, Rades D. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. Strahlenther Onkol. 2010 Feb; 186 (2):70-75 Epub 2010 Jan 26
    View PubMed
  434. Adjei AA, Mandrekar SJ, Dy GK, Molina JR, Adjei AA, Gandara DR, Ziegler KL, Stella PJ, Rowland KM Jr, Schild SE, Zinner RG. Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426. J Clin Oncol. 2010 Feb 1; 28 (4):614-9 Epub 2009 Oct 19
    View PubMed
  435. Rades D, Zwick L, Leppert J, Bonsanto MM, Tronnier V, Dunst J, Schild SE. The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer. 2010 Jan 15; 116(2):432-42.
    View PubMed
  436. Mandrekar SJ, Qi Y, Hillman SL, Allen Ziegler KL, Reuter NF, Rowland KM Jr, Kuross SA, Marks RS, Schild SE, Adjei AA. Endpoints in phase II trials for advanced non-small cell lung cancer. J Thorac Oncol. 2010 Jan; 5 (1):3-9
    View PubMed
  437. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer. 2009 Dec 1; 115 (23):5596-606
    View PubMed
  438. Parker AS, Heckman MG, Wu KJ, Crook JE, Hilton TW, Pisansky TM, Bernard JR, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1364-70. Epub 2009 May 21.
    View PubMed
  439. Rades D, Wolff C, Nadrowitz R, Breunig C, Schild SE, Baehre M, Meller B. Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1226-31. Epub 2009 Apr 06.
    View PubMed
  440. Tribius S, Kronemann S, Kilic Y, Schroeder U, Hakim S, Schild SE, Rades D. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol. 2009 Oct; 185(10):675-81. Epub 2009 Oct 06.
    View PubMed
  441. Qi Y, Schild SE, Mandrekar SJ, Tan AD, Krook JE, Rowland KM, Garces YI, Soori GS, Adjei AA, Sloan JA. Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol. 2009 Sep; 4 (9):1075-82
    View PubMed
  442. Rades D, Fischer D, Veninga T, Stalpers LJ, Schild SE. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer. Gynecol Oncol. 2009 Sep; 114(3):506-8. Epub 2009 Jun 21.
    View PubMed
  443. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy. 2009 Jul-Sep; 8: (3)309-12.
    View PubMed
  444. Foster NR, Mandrekar SJ, Schild SE, Nelson GD, Rowland KM Jr, Deming RL, Kozelsky TF, Marks RS, Jett JR, Adjei AA. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer. 2009 Jun 15; 115 (12):2721-31
    View PubMed
  445. Schild SE. Role of radiation therapy in the treatment of melanoma. Expert Rev Anticancer Ther. 2009 May; 9(5):583-6.
    View PubMed
  446. Rades D, Kueter JD, Pluemer A, Veninga T, Schild SE. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Int J Radiat Oncol Biol Phys. 2009 Mar; 73(4):1077-81.
  447. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26.
    View PubMed
  448. Dy G, Hillman S, Rowland K, Molina J, Steen P, Wender D, Nair S, Mandrekar S, Schild S, Adjei A. A Front-Line "Window of Opportunity" Phase II Study of Sorafenib in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - A North Central Cancer Treatment Group Study N0326. Cancer. 2009.
  449. Rades D, Lange M, Veninga T, Rudat V, Bajrovic A, Stalpers LJ, Dunst J, Schild SE. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys. 2009 Jan; 73(1):228-34.
  450. Rades D, Kueter JD, Hornung D, Veninga T, Hanssens P, Schild SE, Dunst J. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol. 2008 Dec; 184(12):655-62. Epub 2008 Dec 24.
    View PubMed
  451. Rades D, Pluemer A, Veninga T, Schild SE. Comparison of different treatment approaches for one to two brain metastases in elderly patients. Strahlenther Onkol. 2008 Nov; 184(11):565-71. Epub 2008 Nov 19.
    View PubMed
  452. Rades D, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Schild SE. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2008 Nov 1; 72(3):905-8. Epub 2008 Apr 23.
    View PubMed
  453. Rades D, Rudat V, Veninga T, Stalpers LJ, Hoskin PJ, Schild SE. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. Cancer. 2008 Sep 1; 113(5):1090-6.
    View PubMed
  454. Rades D, Golke H, Schild SE, Kilic E. Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy. Strahlenther Onkol. 2008 Aug; 184(8):416-20.
    View PubMed
  455. Rades D, Setter C, Schild SE, Dunst J. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1134-42. Epub 2008 Feb 06.
    View PubMed
  456. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008 May; 83 (5):584-94
    View PubMed
  457. Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2008 May; 184(5):251-5.
    View PubMed
  458. Rades D, Golke H, Schild SE, Kilic E. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. Int J Radiat Oncol Biol Phys. 2008 May 1; 71(1):152-9. Epub 2007 Oct 29.
    View PubMed
  459. Rades D, Kieckebusch S, Haatanen T, Lohynska R, Dunst J, Schild SE. Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Int J Radiat Oncol Biol Phys. 2008 Apr 1; 70(5):1319-24.
    View PubMed
  460. Rades D, Stoehr M, Meyners T, Bohlen G, Nadrowitz R, Dunst J, Schild SE, Wroblewski J, Albers D, Schmidt R, Alberti W, Tribius S. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Strahlenther Onkol. 2008 Apr; 184(4):198-205.
    View PubMed
  461. Rades D, Kuhn H, Schultze J, Homann N, Brandenburg B, Schulte R, Krull A, Schild SE, Dunst J. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. Int J Radiat Oncol Biol Phys. 2008 Mar 15; 70(4):1087-93. Epub 2007 Sep 24.
    View PubMed
  462. Rades D, Stoehr M, Kazic N, Hakim SG, Walz A, Schild SE, Dunst J. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 15; 70(4):1108-14. Epub 2007 Oct 01.
    View PubMed
  463. Rades D, Fehlauer F, Sheikh-Sarraf M, Kazic N, Basic H, Poorter R, Hakim SG, Schild SE, Dunst J. Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer. Head Neck. 2008 Feb; 30(2):235-41.
    View PubMed
  464. Zacharoulis S, Ji L, Pollack IF, Duffner P, Geyer R, Grill J, Schild S, Jaing TH, Massimino M, Finlay J, Sposto R. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors. Pediatr Blood Cancer. 2008 Feb; 50(2):231-5.
    View PubMed
  465. Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, Schild SE, Dahm-Daphi J. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol. 2008 Jan; 184(1):30-5.
    View PubMed
  466. Rades D, Dunst J, Schild SE. The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer. 2008 Jan 1; 112(1):157-61.
    View PubMed
  467. Rades D, Lohynska R, Veninga T, Stalpers LJ, Schild SE. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer. 2007 Dec 1; 110(11):2587-92.
    View PubMed
  468. Rades D, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Dunst J, Schild SE. Reduction of overall treatment time in patients irradiated for more than three brain metastases. Int J Radiat Oncol Biol Phys. 2007 Dec 1; 69(5):1509-13. Epub 2007 Aug 06.
    View PubMed
  469. Schild SE. The role of radiotherapy for limited-stage small cell lung cancer. Am J Hematol Oncol. 2007 Dec; 6(12):673-7.
  470. Rades D, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer. 2007 Nov 15; 110(10):2285-92.
    View PubMed
  471. Rades D, Bohlen G, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Dunst J. Whole-Brain Radiotherapy with 20 Gy in 5 Fractions for Brain Metastases in Patients with Cancer of Unknown Primary (CUP). Strahlenther Onkol. 2007 Nov; 183(11):631-636.
    View PubMed
  472. Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer. 2007 Oct 15; 110(8):1791-5.
    View PubMed
  473. Rades D, Pluemer A, Veninga T, Dunst J, Schild SE. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer. 2007 Oct 1; 110(7):1551-9.
    View PubMed
  474. Rades D, Haatanen T, Schild SE, Dunst J. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. Cancer. 2007 Sep 15; 110(6):1345-50.
    View PubMed
  475. Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ, Dunst J. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer. 2007 Sep 1; 110(5):1077-82.
    View PubMed
  476. Jett JR, Schild SE, Keith RL, Kesler KA, American College of Chest Physicians. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132 (3 Suppl):266S-276S
    View PubMed
  477. Rades D, Schild SE. Spinal cord compression. European Journal of Cancer Supplement 1990. 2007 Sep; 5: (5)359-70.
  478. Sarkaria JN, Schwingler P, Schild SE, Grogan PT, Mladek AC, Mandrekar SJ, Tan AD, Kobayashi T, Marks RS, Kita H, Miller RC, Limper AH, Leof EB. Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer. J Thorac Oncol. 2007 Aug; 2(8):751-7.
    View PubMed
  479. Schild SE, Bonner JA, Hillman S, Kozelsky TF, Vigliotti AP, Marks RS, Graham DL, Soori GS, Kugler JW, Tenglin RC, Wender DB, Adjei A. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). J Clin Oncol. 2007 Jul 20; 25 (21):3124-9
    View PubMed
  480. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer. 2007 Jul 15; 110(2):363-8.
    View PubMed
  481. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68 (4):1053-8 Epub 2007 Mar 29
    View PubMed
  482. Rades D, Fehlauer F, Wroblesky J, Albers D, Schild SE, Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Eur J Cancer B Oral Oncol. 2007 Jul; 43(6):535-43.
  483. Rades D, Schwarz R, Todorovic M, Thurmann H, Graefen M, Walz J, Schild SE, Dunst J, Alberti W. Experiences with a New High-Dose-Rate Brachytherapy (HDR-BT) Boost Technique for T3b Prostate Cancer. Strahlenther Onkol. 2007 Jul; 183(7):398-402.
    View PubMed
  484. Rades D, Bohlen G, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer. 2007 Jun 15; 109(12):2515-21.
    View PubMed
  485. Rades D, Walz J, Schild SE, Veninga T, Dunst J. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone? Urology. 2007 Jun; 69(6):1081-5.
    View PubMed
  486. Rades D, Tribius S, Yekebas EF, Bahrehmand R, Wildfang I, Kilic E, Muellerleile U, Gross E, Schild SE, Alberti W. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study. Int J Radiat Oncol Biol Phys. 2006 Jun 1; 65(2):459-65. Epub 2006 Apr 11.
    View PubMed
  487. Gridelli C, Langer C, Maione P, Rossi A, Schild SE. Lung cancer in the elderly. J Clin Oncol. 2007 May 10; 25(14):1898-907.
    View PubMed
  488. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007 Apr; 82 (4):490-513
    View PubMed
  489. Rades D, Veninga T, Stalpers LJ, Basic H, Hoskin PJ, Karstens JH, Schild SE, Dunst J. Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1506-9.
    View PubMed
  490. Garces YI, Okuno SH, Schild SE, Mandrekar SJ, Bot BM, Martens JM, Wender DB, Soori GS, Moore DF Jr, Kozelsky TF, Jett JR. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67 (4):995-1001
    View PubMed
  491. Leenstra JL, Rodriguez FJ, Frechette CM, Giannini C, Stafford SL, Pollock BE, Schild SE, Scheithauer BW, Jenkins RB, Buckner JC, Brown PD. Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67 (4):1145-54 Epub 2006 Dec 21
    View PubMed
  492. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007 Mar; 82 (3):364-80
    View PubMed
  493. Rades D, Karstens JH, Hoskin PJ, Rudat V, Veninga T, Schild SE, Dunst J. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):525-31. Epub 2006 Dec 04.
    View PubMed
  494. Rades D, Fehlauer F, Veninga T, Stalpers LJ, Basic H, Hoskin PJ, Rudat V, Karstens JH, Schild SE, Dunst J. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):532-7. Epub 2006 Nov 02.
    View PubMed
  495. Rades D, Schulte R, Yekebas EF, Homann N, Schild SE, Dunst J. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer. Strahlenther Onkol. 2007 Jan; 183(1):10-6.
    View PubMed
  496. Rades D, Schild SE, Dunst J. Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer. Int J Gynecol Cancer. 2007 Jan-Feb; 17(1):263-5.
    View PubMed
  497. Rades D, Hoskin PJ, Karstens JH, Rudat V, Veninga T, Stalpers LJA, Schild SE, Dunst J. Radiotherapy of metastatic spinal cord compression in very elderly patients. Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):256-63.
    View PubMed
  498. Rades D, Veninga T, Stalpers LJA, Basic H, Rudat V, Karstens JH, Dunst J, Schild SE. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J Clin Oncol. 2007 Jan 1; 25(1):50-6.
    View PubMed
  499. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol. 2006 Nov; 176 (5):2020-4
    View PubMed
  500. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol. 2006 Sep; 176(3):985-90.
    View PubMed
  501. Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer. 2006 Aug 15; 107(4):781-92.
    View PubMed
  502. Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol. 2006 Jul 20; 24(21):3388-93.
    View PubMed
  503. Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1106-11. Epub 2006 May 26.
    View PubMed
  504. Rades D, Schild SE. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas? Strahlenther Onkol. 2006 Jul; 182(7):415-8.
    View PubMed
  505. Mandrekar SJ, Northfelt DW, Schild SE, Foster NR, Bot B, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Adjei AA, Jett JR. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials. J Thorac Oncol. 2006 Jul; 1(6):556-63.
    View PubMed
  506. Rades D, Schild SE. Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol. 2006 May; 77(3):305-9. Epub 2006 Mar 31.
    View PubMed
  507. Rades D, Schild SE. Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature. J Neurooncol. 2006 May; 77(3):311-4. Epub 2005 Dec 03.
    View PubMed
  508. Rades D, Stalpers LJ, Schulte R, Veninga T, Basic H, Engenhart-Cabilic R, Schild SE, Hoskin PJ. Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. Eur J Cancer. 2006 May; 42(8):1052-6. Epub 2006 Mar 31.
    View PubMed
  509. Rades D, Walz J, Stalpers LJ, Veninga T, Schulte R, Obralic N, Wildfang I, Engenhart-Cabilic R, Hoskin PJ, Schild SE. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study. Eur Urol. 2006 May; 49(5):846-52; discussion 852. Epub 2005 Dec 19.
    View PubMed
  510. Rades D, Hoskin PJ, Stalpers LJ, Schulte R, Poortmans P, Veninga T, Dahm-Daphi J, Obralic N, Wildfang I, Bahrehmand R, Engenhart-Cabilic R, Schild SE. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys. 2006 Apr 1; 64(5):1452-7. Epub 2006 Jan 18.
    View PubMed
  511. Rades D, Schild SE. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer. 2006 Mar 1; 106(5):1140-3.
    View PubMed
  512. Rades D, Lang S, Schild SE, Alberti W. Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer. Clin Oncol (R Coll Radiol). 2006 Mar; 18: (2)139-44.
    View PubMed
  513. Buskirk SJ, Kraft KJ, Witt NJ, Scheuer AK, Gianforti BL, DeGuzman ML, Hunter CA, Guida M, Serago CF, Schild SE, Collie AC. Salvage radiotherapy for patients with increasing prostate-specific antigen levels after radical prostatectomy: Evaluation of the role of retrograde urethrography. Journal of Radiotherapy in Practice. 2006; 5(2):117-20.
  514. Rades D, Veninga T, Stalpers LJ, Schulte R, Hoskin PJ, Poortmans P, Schild SE, Rudat V. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys. 2006 Jan 1; 64(1):182-8. Epub 2005 Sep 28.
    View PubMed
  515. Schild SE, Bogart JA. Innovations in the radiotherapy of non-small cell lung cancer. J Thorac Oncol. 2006 Jan; 1(1):85-92.
    View PubMed
  516. Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR, North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005 Dec 20; 23(36):9113-9.
    View PubMed
  517. Dy GK, Miller AA, Mandrekar SJ, Aubry MC, Langdon RM Jr, Morton RF, Schild SE, Jett JR, Adjei AA. A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Ann Oncol. 2005 Nov; 16 (11):1811-6 Epub 2005 Aug 08
    View PubMed
  518. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc. 2005 Nov; 80(11):1480-4.
    View PubMed
  519. Ma CX, Nair S, Thomas S, Mandrekar SJ, Nikcevich DA, Rowland KM, Fitch TR, Windschitl HE, Hillman SL, Schild SE, Jett JR, Obasaju C, Adjei AA, North Central Cancer Treatment Group//Mayo Clinic//Eli Lilly & Company. Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. J Clin Oncol. 2005 Sep 1; 23 (25):5929-37
    View PubMed
  520. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7.
    View PubMed
  521. Rades D, Schild SE, Yekebas EF, Job H, Schwarz R, Rudat V. Epoetin-alpha during radiotherapy for stage III Esophageal carcinoma - A prospective, nonrandomized study. Cancer. 2005 Jun 1; 103(11):2274-9.
    View PubMed
  522. Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer. 2005 Jun 1; 103(11):2349-54.
    View PubMed
  523. Rades D, Stalpers LJA, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005 May 20; 23(15):3366-75.
    View PubMed
  524. Rades D, Schild SE, Bahrehmand R, Zschenker O, Alberti WA, Rudat VR. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy - The importance of pretreatment hemoglobin levels. Cancer. 2005 Apr 15; 103(8):1740-6.
    View PubMed
  525. Rades D, Fehlauer F, Lamszus K, Schild SE, Hagel C, Westphal M, Alberti W. Well-differentiated neurocytoma: What is the best available treatment? Neuro-oncol. 2005 Jan; 7(1):77-83.
    View PubMed
  526. Rades D, Fehlauer F, Ikezaki K, Schild SE. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas. Radiother Oncol. 2005 Jan; 74(1):67-9.
    View PubMed
  527. Schwartz DJ, Schild SE, Wong WW, Vora SA. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005 Jan 1; 61(1):60-3.
    View PubMed
  528. Rades D, Schild SE, Fehlauer F. Defining the best available treatment for neurocytomas in children. Cancer. 2004 Dec 1; 101(11):2629-32.
    View PubMed
  529. Rades D, Fehlauer F, Stalpers LJA, Wildfang I, Zschenker O, Schild SE, Schmoll HJ, Karstens JH, Alberti W. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression - Final results of a multicenter study. Cancer. 2004 Dec 1; 101(11):2687-92.
    View PubMed
  530. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology. 2004 Oct; 64(4):760-4.
    View PubMed
  531. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Sep 1; 60(1):24-9.
    View PubMed
  532. Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC). Med Dosim. 2004 Fall; 29(3):196-203.
    View PubMed
  533. Gray RJ, Forstner-Barthell AW, Pockaj BA, Schild SE, Halyard MY. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients, with previous implant breast augmentation. Am J Surg. 2004 Aug; 188(2):122-5.
    View PubMed
  534. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug; 27 (4):389-94
    View PubMed
  535. Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH Jr, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59 (4):943-51
    View PubMed
  536. Rades D, Schild SE, Tatagiba M, Molina HA, Alberti W. Therapy of meningeal melanocytomas. Cancer. 2004 Jun 1; 100(11):2442-7.
    View PubMed
  537. Wendt TG, Gademann G, Pambor C, Griessbach I, von Specht H, Martin T, Baltas D, Kurek R, Roddiger S, Tunn UW, Zamboglou N, Eich HT, Staar S, Gossmann A, Hansemann K, Semrau R, Skripnitchenko R, Diehl V, Muller RP, Sehlen S, Willich N, Ruhl U, Lukas P, Duhmke E, Engel K, Tabbert E, Bolck M, Knaack S, Annweiler H, Krempien R, Hoppe H, Harms W, Daeuber S, Schorr O, Treiber M, Debus J, Alber M, Paulsen F, Birkner M, Bakai A, Belka C, Budach W, Grosser KH, Kramer R, Kober B, Reinert M, Schneider P, Hertel A, Feldmann H, Csere P, Hoinkis C, Rothe G, Zahn P, Alheit H, Cavanaugh SX, Kupelian P, Reddy C, Pollock B, Fuss M, Roeddiger S, Dannenberg T, Rogge B, Drechsler D, Herrmann T, Alberti W, Schwarz R, Graefen M, Krull A, Rudat V, Huland H, Fehr C, Baum C, Glocker S, Nusslin F, Heil T, Lemnitzer H, Knips M, Baumgart O, Thiem W, Kloetzer KH, Hoffmann L, Neu B, Hultenschmidt B, Sautter-Bihl ML, Micke O, Seegenschmiedt MH, Koppen D, Klautke G, Fietkau R, Schultze J, Schlichting G, Koltze H, Kimmig B, Glatzel M, Frohlich D, Basecke S, Krauss A, Strauss D, Buth KJ, Bohme R, Oehler W, Bottke D, Keilholz U, Heufelder K, Wiegel T, Hinkelbein W, Rodel C, Papadopoulos T, Munnes M, Wirtz R, Sauer R, Rodel F, Lubgan D, Distel L, Grabenbauer GG, Sak A, Stuben G, Pottgen C, Grehl S, Stuschke M, Muller K, Pfaffendorf C, Mayerhofer A, Kohn FM, Ring J, van Beuningen D, Meineke V, Neubauer S, Keller U, Wittlinger M, Riesenbeck D, Greve B, Exeler R, Ibrahim M, Liebscher C, Severin E, Ott O, Potter R, Hammer J, Hildebrandt G, Beckmann MW, Strnad V, Fehlauer F, Tribius S, Bajrovic A, Holler U, Rades D, Warszawski A, Baumann R, Madry-Gevecke B, Karstens JH, Grehn C, Hensley F, Berns C, Wannenmacher M, Semrau S, Reimer T, Gerber B, Ketterer P, Koepcke E, Hansgen G, Strauss HG, Dunst J, Fuller J, Kalb S, Weitmann HD, Waldhausl C, Knocke TH, Lamprecht U, Classen J, Kaulich TW, Aydeniz B, Bamberg M, Wiezorek T, Banz N, Salz H, Scheithauer M, Schwedas M, Lutterbach J, Bartelt S, Frommhold H, Lambert J, Hornung D, Swiderski S, Walke M, Siefert A, Pollinger B, Krimmel K, Schaffer M, Koelbl O, Bratengeier K, Vordermark D, Flentje M, Hero B, Berthold F, Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Kocher M, Kunze S, Schild S, Ikezaki K, Muller B, Sieber R, Weiss C, Wolf I, Wenz F, Weber KJ, Schafer J, Engling A, Laufs S, Veldwijk MR, Milanovic D, Fleckenstein K, Zeller W, Fruehauf S, Herskind C, Weinmann M, Jendrossek V, Rube C, Appold S, Kusche S, Holscher T, Bruchner K, Geyer P, Baumann M, Kumpf R, Zimmermann F, Schill S, Geinitz H, Nieder C, Jeremic B, Molls M, Liesenfeld S, Petrat H, Hesselmann S, Schafer U, Bruns F, Horst E, Wilkowski R, Assmann G, Nolte A, Diebold J, Lohrs U, Fritz P, Hans-Jurgen K, Muhlnickel W, Bach P, Wahlers B, Kraus HJ, Wulf J, Hadinger U, Hahn SM, Li M, Gong P, Schneider E, Shah VM, Mattke A, Schmitz H, Thoma M, Mayer A, Christian T, et al. [Not Available]. Strahlenther Onkol. 2004 Jun; 180 Suppl 1:5-87.
    View PubMed
  538. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1530-5.
    View PubMed
  539. Rades D, Schild SE, Fehlauer F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology. 2004 Mar 23; 62(6):987-9.
    View PubMed
  540. Rades D, Fehlauer F, Schild SE. Treatment of atypical neurocytomas. Cancer. 2004 Feb 15; 100(4):814-7.
    View PubMed
  541. Macdonald OK, Schild SE. Radiotherapy for a rising PSA following radical prostatectomy. Urol Oncol. 2004 Jan-Feb; 22(1):57-61.
    View PubMed
  542. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol. 2003 Nov; 170(5):1833-7.
    View PubMed
  543. Gunderson LL, Haddock MG, Schild SE. Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment. Semin Radiat Oncol. 2003 Oct; 13(4):419-32.
    View PubMed
  544. Lavertu S, Schild SE, Gunderson LL, Haddock MG, Martenson JA. Endocavitary radiation therapy for rectal adenocarcinoma: 10-year results. Am J Clin Oncol. 2003 Oct; 26(5):508-12.
    View PubMed
  545. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR, North Central Cancer Treatment Group. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol. 2003 Sep 1; 21 (17):3201-6 Epub 2003 July 21
    View PubMed
  546. Rades D, Fehlauer F, Schild S, Lamszus K, Alberti W. Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients [German]. Strahlenther Onkol. 2003 Apr; 179(4):213-8.
    View PubMed
  547. Rades D, Schild SE, Ikezaki K, Fehlauer F. Defining the optimal dose of radiation after incomplete resection of central neurocytomas. Int J Radiat Oncol Biol Phys. 2003 Feb 1; 55(2):373-7.
    View PubMed
  548. Macdonald OK, Schild SE. Radiotherapy for a Rising PSA Following Radical Prostatectomy. Urologic Oncology : Seminars and Original Investigations. 2003; 22(1).
  549. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54 (3):729-34
    View PubMed
  550. Schild SE, Stella PJ, Geyer SM, Bonner JA, Marks RS, McGinnis WL, Goetz SP, Kuross SA, Mailliard JA, Kugler JW, Schaefer PL, Jett JR. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54 (2):370-8
    View PubMed
  551. Schild SE, Wong WW, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy (TID RT) and escalating doses of daily cisplatin (CDDP) for patients with locally advanced non-small cell lung cancer . Int J Radiat Oncol Biol Phys. 2002 Oct; 54(3):93-8.
  552. Lutterbach J, Fauchon FO, Schild SE, Chang SM, Pagenstecher A, Volk B, Ostertag C, Momm F, Jouvet A. Malignant pineal parenchymal tumors in adult patients: Patterns of care and prognostic factors. Neurosurgery. 2002 Jul; 51(1):44-55.
    View PubMed
  553. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol. 2002 May; 80(1):19-25; discussion 26.
    View PubMed
  554. Kresl JJ, Schild SE, Henning GT, Gunderson LL, Donohue J, Pitot H, Haddock MG, Nagorney D. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys. 2002 Jan 1; 52 (1):167-75
    View PubMed
  555. Schild SE, Pisansky TM. The role of radiotherapy after radical prostatectomy. Urol Clin North Am. 2001 Aug; 28 (3):629-37, x
    View PubMed
  556. Buskirk SJ, Pisansky TM, Atkinson EJ, Schild SE, O'Brien PC, Wolfe JT, Zincke H. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy. Mayo Clin Proc. 2001 Jul; 76(7):702-6.
    View PubMed
  557. Schild SE. Radiation therapy (RT) after prostatectomy: The case for salvage therapy as opposed to adjuvant therapy. Int J Cancer. 2001 Apr 20; 96: (2)94-8.
    View PubMed
  558. Ezzell GA, Schild SE, Wong WW. Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy. J Appl Clin Med Phys. 2001 Spring; 2 (2):59-68
    View PubMed
  559. Schild SE. An Analysis of Radiation Therapy for an Elevated PSA Level after Radical Prostatectomy, Consensus Statements on Radiation Therapy of Prostate Cancer. Oncologia Clinica. 2000 Sept; 5(3):423-4.
  560. Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, Cheville JC, Ferrigni RG, Schild SE. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000 Mar; 163(3):845-50.
    View PubMed
  561. Henning GT, Schild SE, Stafford SL, Donohue JH, Burch PA, Haddock MG, Trastek VF, Gunderson LL. Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2000 Feb 1; 46 (3):589-98
    View PubMed
  562. Henning GT, Schild SE, Stafford SL, Donohue JH, Burch PA, Haddock MG, Gunderson LL. Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2000 Jan 1; 46 (1):109-18
    View PubMed
  563. Magrina JF, Walter AJ, Schild SE. Laparoscopic radical parametrectomy and pelvic and aortic lymphadenectomy for vaginal carcinoma: A case report. Gynecol Oncol. 1999 Dec; 75(3):514-6.
    View PubMed
  564. Brown PD, Stafford SL, Schild SE, Martenson JA, Schiff D. Metastatic spinal cord compression in patients with colorectal cancer. J Neurooncol. 1999 Sep; 44 (2):175-80
    View PubMed
  565. Schild SE. An Analysis of Radiation Therapy for an Elevated PSA Level after Radical Prostatectomy. J Clin Oncol. 1999; 17:1161-2.
  566. Schild SE, Nisi K, Scheithauer BW, Wong WW, Lyons MK, Schomberg PJ, Shaw EG. The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1998 Dec 1; 42 (5):953-8
    View PubMed
  567. Schild SE, Stafford SL, Brown PD, Wood CP, Scheithauer BW, Schomberg PJ, Wong WW, Lyons MK, Shaw EG. The results of radiotherapy for brainstem tumors. J Neurooncol. 1998 Nov; 40 (2):171-7
    View PubMed
  568. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998 Sep 1; 42 (2):351-60
    View PubMed
  569. Schild SE. Radiation therapy after prostatectomy: now or later? Semin Radiat Oncol. 1998 Apr; 8 (2):132-9
    View PubMed
  570. Haddock MG, Schild SE, Scheithauer BW, Schomberg PJ. Radiation therapy for histologically confirmed primary central nervous system germinoma. Int J Radiat Oncol Biol Phys. 1997 Jul 15; 38 (5):915-23
    View PubMed
  571. Foote RL, Coffey RJ, Gorman DA, Earle JD, Schomberg PJ, Kline RW, Schild SE. Stereotactic radiosurgery for glomus jugulare tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1997 Jun 1; 38 (3):491-5
    View PubMed
  572. Schild SE, Wong W. The role of retrograde urethrography in the planning of prostate cancer radiotherapy. Med Dosim. 1997 Summer; 22 (2):83-6
    View PubMed
  573. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol. 1997 Mar; 15(3):1239-43.
    View PubMed
  574. Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW, Lyons MK. Central neurocytomas. Cancer. 1997 Feb 15; 79 (4):790-5
    View PubMed
  575. Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys. 1997 Jan 1; 37 (1):51-8
    View PubMed
  576. Schild SE, Scheithauer BW, Haddock MG, Wong WW, Lyons MK, Marks LB, Norman MG, Burger PC. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer. 1996 Dec 15; 78 (12):2564-71
    View PubMed
  577. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9.
    View PubMed
  578. Schild SE, Haddock MG, Scheithauer BW, Marks LB, Norman MG, Burger PC, Wong WW, Lyons MK, Schomberg PJ. Nongerminomatous germ cell tumors of the brain. Int J Radiat Oncol Biol Phys. 1996 Oct 1; 36 (3):557-63
    View PubMed
  579. Lyons MK, Gonzales GR, Schild SE, Nelson KD. Radiation-induced meningioma following radiation therapy for pituitary adenoma. Case report. Neurosurg Focus. 1996 Jul 15; 1 (1):e8; discussion 1 p following e8 Epub 1996 July 15
    View PubMed
  580. Wong WW, Schild SE, Martenson JA. Role of Radiation Therapy and Fluoropyrimidines in the Treatment of Gastrointestinal Malignancies. Cancer Control. 1996 Jul; 3 (4):319-328
    View PubMed
  581. Schild SE, Wong WW, Novicki DE, Ferrigni RG, Swanson SK. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay. Urology. 1996 Jun; 47(6):878-81.
    View PubMed
  582. Buskirk SJ, Schild SE, Durr ED, Robinow JS, Bock FF, Wolfe JT, Tomera KM, Ferrigni RG. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer. Mayo Clin Proc. 1996 Mar; 71 (3):242-8
    View PubMed
  583. Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34 (3):585-90
    View PubMed
  584. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34 (3):535-41
    View PubMed
  585. Schild SE, Martenson JA, Gunderson LL. Endocavitary radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34 (3):677-82
    View PubMed
  586. Schild SE, Wharen RE Jr, Menke DM, Folger WN, Colon-Otero G. Primary lymphoma of the spinal cord. Mayo Clin Proc. 1995 Mar; 70 (3):256-60
    View PubMed
  587. Schild SE, Wong WW, Grado GL, Buskirk SJ, Ferrigni RL. The Use of Radiotherapy for Patients with Isolated Elevation of Serum PSA Levels following Radical Prostatectomy. Radiology. 1995; 294:293.
  588. Wong WW, Pluth JR, Grado GL, Schild SE, Sanderson DR. Liposarcoma of the pleura. Mayo Clin Proc. 1994 Sep; 69 (9):882-5
    View PubMed
  589. Schild SE, Wong WW, Grado GL, Buskirk SJ, Ferrigni RL. The Use of Radiotherapy for Patients with Isolated Elevation of Serum PSA Levels following Radical Prostatectomy. Clinical Oncology Alert. 1994 Sept; 9(9):65-7.
  590. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc. 1994 Jul; 69 (7):613-9
    View PubMed
  591. Foote RL, Schild SE, Thompson WM, Buskirk SJ, Olsen KD, Stanley RJ, Kunselman SJ, Schaid DJ, Grill JP. Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer. 1994 May 15; 73 (10):2638-47
    View PubMed
  592. Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L, Robinow JS, Buskirk SJ. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993 Aug 1; 72 (3):870-80
    View PubMed
  593. Schild SE, Casale HE, Bellefontaine LP. Movements of the prostate due to rectal and bladder distension: implications for radiotherapy. Med Dosim. 1993 Spring; 18 (1):13-5
    View PubMed
  594. Schild SE, Foote RL, Buskirk SJ, Robinow JS, Bock FF, Cupps RE, Earle JD. Results of radiotherapy for chemodectomas. Mayo Clin Proc. 1992 Jun; 67 (6):537-40
    View PubMed
  595. Buskirk SJ, Gunderson LL, Schild SE, Bender CE, Williams HJ Jr, McIlrath DC, Williams HJ Jr, Robinow JS, Tremaine WJ, Martin JK Jr, Martin JK Jr. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg. 1992 Feb; 215 (2):125-31
    View PubMed
  596. Schild SE, Buskirk SJ, Robinow JS, Tomera KM, Ferrigni RG, Frick LM. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys. 1992; 23 (1):141-5
    View PubMed
  597. Schild SE, Buskirk SJ, Robinow JS. Prostate cancer: retrograde urethrography to improve treatment planning for radiotherapy. Radiology. 1992; 181:885-887.
  598. Schild SE, Robinow JS, Casale HE, Bellefontaine LP, Buskirk SJ. Radiotherapy treatment planning for prostate cancer in patients with prosthetic hips. Med Dosim. 1992; 17 (2):83-6
    View PubMed
  599. Schild SE, Buskirk SJ, Robinow JS. Prostate cancer: retrograde urethrography to improve treatment planning for radiation therapy. Radiology. 1991 Dec; 181: (3)885-7.
    View PubMed
  600. Schild SE, Buskirk SJ, Frick LM, Cupps RE. Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys. 1991 Aug; 21 (3):729-35
    View PubMed
  601. Schild SE, Martenson JA Jr, Gunderson LL, Ilstrup DM, Berg KK, O'Connell MJ, Weiland LH. Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival, and prognostic factors. Int J Radiat Oncol Biol Phys. 1989 Jul; 17 (1):55-62
    View PubMed
  602. Schild SE, Martenson JA Jr, Gunderson LL, Dozois RR. Long-term survival and patterns of failure after postoperative radiation therapy for subtotally resected rectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 1989 Feb; 16 (2):459-63
    View PubMed
PST-20220854